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VABSTRACT
Glial cell line-derived neurotrophic factor (GDNF), neurturin (NRTN), artemin (ARTN)
and persephin (PSPN) constitute the GDNF family of neurotrophic factors, which belongs to the
transforming growth factor-β superfamily. The members of the GDNF family appear to play
crucial roles in the development, differentiation and maintenance of various populations of
vertebrate neurons (reviewed by Airaksinen et al. 1999 and Baloh et al. 2000a). Biological
actions of the GDNF family members are mediated via a multicomponent receptor complex,
which consists of glycosylphosphatidylinositol (GPI)-linked ligand-binding α−components,
designated GDNF family receptor alpha (GFRα) 1 through 4, and the signal transducing receptor
tyrosine kinase Ret.
The kainate-induced seizure model, a widely studied model of neuronal plasticity and
human epilepsy, was applied to investigate whether the mRNAs for the GDNF receptor
components Ret and GFRα1 are regulated in the adult rat brain by neuronal activity. To examine
the physiological significance and ligand specificity of the GFRα proteins we generated and
analyzed mice which are deficient in GFRα2. There was a special interest in investigating
whether the GDNF family members, especially GDNF and NRTN, might regulate the
development and/or functioning of penile erection inducing neurons in the adult rat.
The data showed that the mRNAs for the GDNF receptors Ret and GFRα1 are induced in
the rat brain in response to systemic administration of kainate. The kainate induced upregulation
of GFRα1 mRNA, but not Ret mRNA, was significantly suppressed in the hippocampus by the
protein synthesis inhibitor cycloheximide. These results suggest that GFRα1 belongs to late-
response genes, as protein synthesis is necessary for its mRNA’s induction by kainate. MK-801,
the N-methyl-D-aspartate (NMDA)-receptor antagonist, suppressed the behavioral seizures, but
did not significantly suppress elevated levels of Ret or GFRα1 mRNA, suggesting that non-
NMDA receptors are responsible for the induction of their mRNAs following kainate-induced
seizures.
Analysis of GFRα2-/- mice showed that cholinergic innervation was almost absent in the
lacrimal and salivary glands, and dramatically reduced in the myenteric plexus of the small
intestine, whereas the sympathetic innervation was normal. The striking similarites in the
phenotypes of mice lacking GFRα2 or NRTN, which include deficits in both parasympathetic
and enteric neurons, provide strong support for the idea that GFRα2/Ret receptor complexes are
the primary mediators of NRTN function in vivo. In addition the number of nitric oxide synthase
VI
(NOS)-containing nerve fibers was reduced in the penis of GFRα2-/- mice. This points to a
physiological role of GFRα2-mediated signaling in penile erection-inducing neurons.
Both NRTN and GDNF mRNAs are expressed in the shaft of the adult rat penis. In contrast
to the expression of GDNF, NRTN expression was also seen in several intrapelvic organs. The
GDNF family receptor components Ret and GFRα1-GFRα3 were expressed in partially distinct
and overlapping populations of penile major pelvic ganglion (MPG) neurons, as well as in most
other neurons of adult rat MPG. This conforms to the idea that in the adult rat certain GDNF
family members may maintain not only penile parasympathetic, but also other pelvic autonomic
neurons. In addition, the results showed that penile parasympathetic and sensory nerves are able
to internalize and retrogradely transport to neuronal somata 125I-GDNF and 125I-NRTN injected
into the shaft of the penis, apparently mediated by binding of these proteins to specific receptors
at the axon terminals.
In conclusion, the present set of studies suggest that GDNF and its receptors Ret and
GFRα1 may play a crucial role in neuronal plasticity following epileptic insults. Analysis of
GFRα2-deficient mice implicates GFRα2 as a physiological NRTN receptor, crucial for the
development and/or maintenance of specific postganglionic parasympathetic as well as enteric
innervation. In addition, these results suggest that both NRTN and GDNF may act as a target-
derived survival and/or neuritogenic factor for penile erection-inducing postganglionic neurons,
as well as for other MPG neurons of the adult rat.
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11. INTRODUCTION
Neurotrophic proteins were originally
identified as survival factors. Ablation and
transplantation studies of peripheral target
tissues suggested that neuronal cell death
during development is regulated by limited
production of neurotrophic proteins in their
projection field (Levi-Montalcini 1987). It is
now known that neurotrophic factors regulate
neuronal survival during development, adult
nervous system plasticity, and maintenance
of structural integrity (Davies 1994;
Henderson 1996; McAllister et al. 1999).
Since structural damage and reactive
plasticity are characteristics of chronic
neurodegenerative diseases, the neurotrophic
factors are likely to be involved in
neurodegeneration (Hefti 1994). Nerve
growth factor (NGF), the first identified and
most studied neurotrophic protein, was found
and purified as early as 1952 from mouse
sarcoma tissue based on its ability to
stimulate neurite outgrowth from sensory and
postganglionic sympathetic nerve cells (for
review, see Levi-Montalcini 1987). For
several decades NGF was the only known
protein to regulate neuronal survival and
differentiation. During the last two decades
the field of neurotrophic factors has advanced
very rapidly and a whole NGF-family of
growth factors (neurotrophins) and many
other neurotrophic factors have been
discovered (Hefti 1997; Skaper et al. 1998).
Glial cell line-derived neurotrophic
factor (GDNF) was originally isolated based
on its ability to promote in culture the
survival and differentiation of embryonic
midbrain dopaminergic neurons (Lin et al.
1993). Later it has been shown to promote the
survival of several types of neurons both in
the central and peripheral nervous system
(Saarma and Sariola 1999). GDNF has
received attention as a potential therapeutic
agent for certain neurodegenerative diseases,
e.g. Parkinson’s disease (Lapchak et al.
1997). Recently, three GDNF-releated
proteins, neurturin (NRTN), artemin
(ARTN), and persephin (PSPN) were
identified (Kotzbauer et al. 1996; Baloh et al.
1998a; Milbrandt et al. 1998). These four
neurotrophic factors comprise the GDNF
family of neurotrophic factors. The GDNF
family members mediate their biological
actions via a multicomponent receptor
complex, which consists of
glycosylphosphatidylinositol (GPI)-linked
ligand-binding receptors GDNF family
receptor α:s (GFRα1 through GFRα4), and
the signal transducing receptor tyrosine
kinase Ret (for review, see Airaksinen et al.
1999; Baloh et al. 2000a).
The present series of studies was
carried out to further elucidate the roles of the
GDNF family of neurotrophic factors both in
the central and peripheral nervous system.
The regulation of Ret and GFRα1 mRNA in
the rat brain was studied after kainate-
induced seizures, a widely studied model of
neuronal plasticity and human epilepsy. The
GFRα2-deficient (GFRα2-/-) mice were
generated and analyzed to assess the in vivo
function of GFRα2 and the physiological
relevance of its ligand specificity. Attempts
2were also made to clarify whether NRTN and
GDNF fulfil some of the basic criteria for
being neurotrophic factors for penile erection
inducing neurons. This was approached by
studying the expression of their receptor
components in penile parasympathetic and
sensory neurons. Retrograde axonal transport
of iodinated GDNF and NRTN in penile
nerves was assessed to confirm the existence
of functional receptors in axon terminals.
2. REVIEW OF THE LITERATURE
2.1. Introduction to the GDNF family of
neurotrophic factors
GDNF and the related factors NRTN,
PSPN and ARTN comprise the GDNF
family, a novel family of neurotrophic factors
(fig. 2.1.). The GDNF family ligands are
basic, dimeric, secreted molecules which
have formed a new subgroup in the
transforming growth factor (TGF) -β
superfamily (for reviews, see Airaksinen et
al.1999; Saarma and Sariola 1999; Baloh et
al. 2000a).
The first member of this family, GDNF,
was discovered based on its ability to
increase high-affinity dopamine uptake and
promote survival and morphological
differentiation of dopaminergic neurons in
embryonic midbrain cultures (Lin et al.
1993). GDNF is an extracellular glycosylated
disulfide-bonded homodimer that is
synthesized as a 211 amino acids precursor
and the mature protein consists of 134 amino
acids. Interestingly, there are two potential
glycosylation sites in the mature protein,
which has a Mr of 18 to 22 kDa. Despite the
fact that GDNF showed less than 20 percent
amino acid sequence similarity with the
members of the TGF-β superfamily (Lin et
al. 1993), the pattern of cysteine residues
made it a member of this superfamily, which
is characterized by head to tail dimerization
supported by a single interchain disulphide
bond (Kingsley 1994). The sequence of
GDNF places it also in the cysteine knot
growth factor superfamily (Lin et al. 1993).
The members of this superfamily are dimeric
proteins characterized by a topological knot
formed by three cysteines, in which two
cysteines and adjacent amino acids form a
covalent ring which is passed by the third
cysteine (McDonald et al. 1991).
Determination of the crystal structure of
GDNF at 1.9 Å resolution showed that
GDNF has many similar features with two
structurally characterised members of the
TGF-β superfamily: TGF-β2 and BMP-7
(Eigenbrot and Gerber 1997).
3Figure 2.1. Schematic structure of the GDNF family members. The relative lengths of the mature
proteins (number of amino acids), and of the pre- and proregions, as well as the relative positions of the
seven conserved cysteine residues (white lines) are shown. Glial cell line-derived neurotrophic factor
(GDNF), neurturin (NRTN), artemin (ARTN), and persephin (PSPN). Modified from Airaksinen et al.
(1999) by permission of Academic Press, copyright © 1999.
GDNF is a multipotent neurotrophic
factor that has a variety of effects on cells
both in the central and peripheral nervous
systems, including midbrain dopaminergic
neurons (Lin et al. 1993; Beck et al. 1995;
Sauer et al. 1995; Tomac et al. 1995; Gash et
al. 1996; Messer et al. 2000), spinal
motoneurons (Henderson et al. 1994;
Oppenheim et al. 1995; Yan et al. 1995),
peripheral sensory and autonomic neurons
(Buj-Bello et al. 1995; Ebendal et al. 1995;
Oppenheim et al. 1995; Trupp et al. 1995;
Forgie et al. 1999; Hashino et al. 1999),
central noradrenergic (Arenas et al. 1995), as
well as basal forebrain cholinergic neurons
(Williams et al. 1996).
NRTN, the second member of the
GDNF family, was identified on the basis of
its ability to support the survival of
sympathetic postganglionic neurons in
culture (Kotzbauer et al. 1996). Mouse
preproNRTN is a 195-amino acids long
protein which has been predicted to contain
19-amino acid signal sequence and a 76-
amino acid proregion. Proteolytic cleavage
of the precursor should yield a 100-residue
mature protein with a 42 percent similarity
with mature GDNF. The mature mouse
NRTN has a predicted Mr of 11.5 kDa.
NRTN promotes the survival of several
populations of neurons both in the central
and peripheral nervous systems, e.g. spinal
cord motoneurons (Klein et al. 1997),
GDNF
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4sensory neurons of nodose and dorsal root
ganglia (Kotzbauer et al. 1996),
parasympathetic submandibular neurons
(Cacalano et al. 1998), enteric neurons
(Heuckeroth el al. 1998; Taraviras et al.
1999) and substantia nigra dopaminergic
neurons (Horger et al. 1998; Tseng et al.
1998).
Also PSPN promotes the survival of
spinal cord motoneurons and midbrain
dopaminergic neurons (Milbrandt et al.
1998; Soler et al. 1999). Surprisingly, PSPN
seems to be inactive on peripheral neurons.
It was cloned using degenerate primers
designed for the region of high similarity to
GDNF and NRTN (Milbrandt et al. 1998).
PSPN is about 40 percent identical with
GDNF and NRTN. However, the prepro
PSPN molecule is considerably smaller (156
residues) than NRTN or GDNF (195 and
211 residues, respectively) (Milbrandt et al.
1998). This may be of significance, since
both GNDF and NRTN have two RXXR
cleavage sites in their long prodomains,
whereas PSPN has only one. Therefore, two
mature species of GDNF and NRTN may
exist.
ARTN, the most recently discovered
member of the GDNF family, was identified
by searching the high throughput genome
sequences (HTGS) database, with a mature
human NRTN protein sequence as a query
(Baloh et al. 1998a). ARTN promotes the
survival of peripheral ganglia and
dopaminergic neurons in vitro. It is
synthesized as a 220 amino acid precursor
that is processed and secreted as a mature
protein of 113 amino acids. Alignment of the
predicted mature ARNT protein with the
other GDNF family members indicates that
ARTN has about 45 percent identity with
NRTN and PSPN, whereas the identity with
GDNF is only 36 percent. The large
proregion of ARTN is separated from the
mature region by multiple conserved RXXR
cleavage sites. ARTN is also most probably
a cysteine knot protein like the other GDNF
family members (Baloh et al. 1998a).
Recently Masure et al. (1999) described the
molecular cloning and functional
characterization of enovin, a protein which is
identical with ARTN. Interestingly, they
found in most tissues several differentially
spliced mRNA variants for enovin, of which
only two could be translated into functional
enovin proteins. Some tissues seem to
express only nonfunctional transcripts
(Masure et al. 1999).
2.2. Introduction to the GDNF family
receptors
Although the GDNF family ligands are
members of the TGF-β superfamily they
share a receptor system that is more similar
to that of cytokines, in that a common
signaling receptor is used and additional
ligand-binding subunits provide the ligand
specificity (fig. 2.2.) (for reviews, see
Kingsley 1994; Ibáñez 1998; Airaksinen et
al. 1999).
5Figure 2.2. Schematic representation of GDNF family ligand-receptor interactions. All the GDNF
family members activate the signaling Ret tyrosine kinase receptor via different glycosyl-
phosphatidylinositol (GPI)-anchored coreceptors called GFRα1-4. Thick arrows represent the functional
binding that activates Ret most potently, and that predominates most probably in vivo, whereas the
interactions indicated by the dotted lines may not be physiologically significant in vivo. Recent
experimental evidence suggests that GDNF may also signal Ret-independently via GFRα1. So far ligand
interactions of the coreceptor GFRα4 have been characterized in the chicken only. Modified from
Airaksinen et al. (1999) by permission of Academic Press, copyright © 1999.
The common signaling receptor for the
GDNF family ligands is Ret receptor tyrosine
kinase which is expressed in practically all
cells, in which GDNF family ligands have
displayed activity. The Ret gene was
originally discovered as an oncogene
activated by rearrangement during
transformation (Takahashi and Cooper 1987).
Germline mutations in Ret have been
associated in an inherited cancer syndrome
called multiple endocrine neoplasia type 2
(MEN 2), and Hirschsprung’s disease
(HSCR; aganglionic megacolon) (Edery et al.
1994; Hofstra et al. 1994; Romeo et al. 1994).
Somatic mutations in the Ret gene have also
been found in a variety of sporadic cancer
types (for review, see Eng 1999). Ret was
identified as the signaling receptor for GDNF
by several groups almost simultaneously
(Durbec et al. 1996a; Jing et al. 1996;
Treanor et al. 1996; Trupp et al. 1996; Worby
et al. 1996). The association of Ret and
GDNF was illuminated by their
complementary expression in adjacent tissues
and the almost similar phenotypes of mice
deficient in GDNF or Ret (Schuchardt et al.
1994; Moore et al. 1996; Pichel et al. 1996;
Sanchez et al. 1996; Suvanto et al. 1996).
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6The GDNF family ligands bind to
glycosylphosphatidyl inositol (GPI)-anchored
coreceptors, which are members of the GFRα
family, to form a complex that subsequently
activates the Ret tyrosine kinase (Jing et al.
1996; Treanor et al. 1996; Trupp et al. 1996;
Baloh et al. 1997; Buj-Bello et al. 1997;
Creedon et al. 1997; Klein et al. 1997;
Sanicola et al. 1997). GFRα1 (formerly
GDNFR-α) was the first identified member
of the GFRα family, and it was discovered by
expression cloning and screening for GDNF
binding (Jing et al. 1996; Treanor et al.
1996). Soon after identification of GFRα1
both GFRα2 (Baloh et al. 1997; Buj-Bello et
al. 1997; Jing et al. 1997; Klein et al. 1997;
Sanicola et al. 1997; Suvanto et al. 1997;
Widenfalk et al. 1997) and GFRα3 (Jing et
al. 1997; Baloh et al. 1998b; Masure et al.
1998; Naveilhan et al. 1998; Nomoto et al.
1998; Trupp et al. 1998; Widenfalk et al.
1998; Worby et al. 1998) were cloned based
on their sequence homology with GFRα1.
Finally, GFRα4 was cloned by screening an
embryonic chicken brain cDNA library with
a GFRα1 probe at low stringency (Thompson
et al. 1998).
2.3. Cross-talk within and specificity of the
GDNF family ligand-GFRα system
In vitro experiments by multiple groups
indicate that ligand-receptor interactions
show certain specificity within the GDNF
family (fig. 2.2.). Although there is some
cross-talk, GFRα1 seems to be the primary
coreceptor for GDNF and GFRα2 for NRTN.
In cell culture both GFRα1 and GFRα2
mediate GDNF induced Ret phosphorylation
with similar efficiency (Baloh et al. 1997;
Jing et al. 1997; Sanicola et al. 1997; Suvanto
et al. 1997). However, they seem to function
in a mechanistically distinct way. In vitro
binding experiments with soluble forms of
Ret, GFRα1 and GFRα2 show that, in
contrast to GFRα1, GFRα2 binds GDNF
with high affinity only in the presence of Ret
(Klein et al. 1997; Sanicola et al. 1997),
whereas in intact cells specific interaction
between GDNF and GFRα2 is also seen in
the absence of Ret (Trupp et al. 1998). NRTN
has a higher affinity for GFRα2 than for
GFRα1 (Jing et al. 1997; Klein et al. 1997).
NRTN is also more efficient in inducing Ret
phosphorylation via GFRα2 (Baloh et al.
1997). ARTN seems to signal through Ret
using GFRα3 as the primary coreceptor
(Baloh et al. 1998a). Soluble GFRα3 binds
directly to ARTN but not to any other GDNF
family ligand (Baloh et al. 1998a). However,
direct ligand-binding studies with soluble
GFRα proteins have been unreliable in
predicting the GDNF family interactions
since Ret may modulate receptor binding
specificites (Sanicola et al. 1997). In
experiments where mitogen-activated protein
kinase (MAPK) activity was tested in cells
expressing Ret and different GFRα
components, ARTN was the only GDNF
family member which activated the GFRα3-
Ret receptor complex (Baloh et al. 1998a). It
also activated the GFRα1-Ret receptor
complex suggesting that ARTN may utilize
not only the GFRα3-Ret receptor complex
7but also the GFRα1-Ret complex in some
systems in vivo (Baloh et al. 1998a). PSPN
seems to signal through the GFRα4-Ret
receptor complex (Enokido et al. 1998).
Mouse PSPN binds specifically to microtitre
plates coated with chicken GFRα4-IgG as
well as to human embryonic 293 kidney cells
expressing chicken GFRα4 (Enokido et al.
1998). Enokido et al. (1998) provided
evidence that a high concentration of NRTN
can promote the survival of neurons
coexpressing Ret and GFRα4, although not
as effectively as much lower concentrations
of PSPN. Whether the ligand specificity of
the mammalian GFRα4 coreceptor is
comparable to that of chicken GFRα4
remains, however, to be studied.
Recently, Baloh et al. (2000b)
identified by comprehensive homologue-
scanning mutagenesis two distinct sites of the
GDNF molecule critical for activating the
GFRα1-Ret receptor complex. They further
demonstrated that chimeric mutants produced
by introducing these two regions of any
GFRα1 agonist (GDNF, NRTN, ARTN) into
the structure of the PSPN molecule, serve as
GFRα1-Ret-specific agonists in vitro. In
addition, they reported the existence of at
least one additional region critical for the
alternate GFRα2-Ret interaction (Baloh et al.
2000b).
2.4. Structural similarities and differences
between GFRα molecules
Rat GFRα1, the first identified member
of the GFRα family is a protein made up of
468 amino acids (Jing et al. 1996; Treanor et
al. 1996). Its amino acid sequence contains a
signal peptide, 3 potential glycosylation sites,
and 31 cysteine residues. The spacing of
these cysteines is not related to that found in
any of the extracellular cystein-rich domains
of receptor proteins cloned before it (Jing et
al. 1996). The hydrophobic cluster at the
carbon terminus is preceded by a group of
three small amino acids (Ala, Ser, Ser),
defining a cleavage site for GPI-linkage
suggesting that GFRα1 is an extracellular
protein attached to cell membrane by a
glycolipid anchor (Micanovic et al. 1990).
Rat GFRα2 is a 464 amino acid residue
polypeptide with 6 potential glycosylation
sites and it shows 49 percent identity with
GFRα1 (Suvanto et al. 1997; Trupp et al.
1998). In human 30 cysteines out of 31 are
present in both GFRα1 and GFRα2  with
nearly identical spacing, indicating a
conserved cysteine backbone structure (Baloh
et al. 1997; Klein et al. 1997; Sanicola et al.
1997). Mouse GFRα3 is a 397 amino acid
residue polypeptide with 32% and 37%
amino acid identity with GFRα1 and GFRα2,
respectively (Naveilhan et al. 1998). Like
GFRα1 and GFRα2, GFRα3 contains a
possible signal sequence, three potential
glycosylation sites and a putative GPI-linked
hydrophobic carbon terminus (Masure et al.
1998; Naveilhan et al. 1998). Analysis of the
gene structure for both GFRα3 and GFRα2
confirmed that the C-terminal region, absent
from GFRα3, is not the result of alternative
splicing in the cDNAs (Baloh et al. 1998b).
All 28 cysteines of GFRα3 were conserved in
8GFRα1 and GFRα2 (Naveilhan et al. 1998).
GFRα3 has a lower homology to GFRα1 or
GFRα2 than GFRα1 and GFRα2 have to
each other, suggesting that GFRα3 is a more
distant member in this family of receptors
(Masure et al. 1998; Naveilhan et al. 1998;
Worby et al. 1998). GFRα3 is located in the
human chromosome 5, q31.1-q31.3 region,
whereas GFRα1 and GFRα2 are located at
chromosome 10, region q25 and chromosome
8, region p22-p21, respectively (Masure et al.
1998).
The nucleotide sequence of chicken
GFRα4 predicts a 431 amino acid protein
that is more closely related to GFRα1 and
GFRα2 than to GFRα3 (Thompson et al.
1998). Sequence alignment shows that
GFRα4 has approximately 40% amino acid
identity with both mouse and chicken GFRα1
and GFRα2, whereas it has only 27% identity
with mouse GFRα3. Of the 30 cysteines that
are conserved in GFRα1 and GFRα2, 28 are
conserved in GFRα4 (Thompson et al. 1998).
Recently a putative mouse GFRα4 gene was
identified (Gunn et al. 1999) and cDNA
cloned (Lindahl et al. 2000). The mouse
GFRα4 protein is smaller than the other
GFRα:s consisting of 263 amino acids with
C-terminal sequences typical for a putative
GPI-anchored protein (Lindahl et al. 2000). It
shows only 53% amino acid identity with
chicken GFRα4, and undergoes
developmentally regulated alternative
splicing in several tissues. Efficiently spliced
GFRα4 transcripts have been detected in the
thyroid, parathyroid, and adrenal glands that
are tissues affected in MEN 2 cancer
syndrome, suggesting a causal link (Lindahl
et al. 2000).
Based on the sequence homology and
conserved cysteine structure a putative
domain structure has been suggested for the
members of the GFRα family (Suvanto 1997;
Airaksinen et al. 1999). There are three about
100 amino acids comprising cysteine-rich
domains in the GFRα1-3 proteins, whereas
the mammalian GFRα4 receptor lacks the
first cysteine-rich domain characteristic of
other GFRα proteins (Lindahl et al. 2000).
The domains are held together by short hinge
regions. The GFRα2 protein has an
additional short cysteine-rich domain at the
C-terminal region (Suvanto 1997).
2.5. GDNF family signaling
2.5.1. Ret-dependent activation of
intracellular pathways
The structure and signal transduction
pathways of the Ret tyrosine kinase receptor
are summarized in fig. 2.3. The human Ret
proto-oncogene, localized to chromosomal
region 10q11.2, encodes the transmembrane
receptor tyrosine kinase (RTK) that is mainly
expressed in tissues derived from the neural
crest. Ret comprises a cadherin-homology
domain, a cysteine-rich region, a trans-
membrane domain, and intracellular tyrosine
kinase domains (Takahashi and Cooper
1987).
9Figure 2.3. Proposed structure and intracellular signaling pathways of Ret. The phosphorylated
tyrosine residues (-(P)Y) in Ret, which are used as docking sites for adaptor proteins, are shown. The
figure shows that Ret activates several intracellular pathways typical of receptor tyrosine kinase signaling,
including Ras-MAPK, phosphoinositol-3-kinase (PI3-K), Jun N-terminal kinase (JNK), and
PLCγ−dependent pathways. The most common activating mutation sites of Ret in the cancer syndromes
familial medullary thyroid cancer (FTMC), and multiple endocrine neoplasia 2 (MEN2), are shown on the
right side. The dotted line shows the relative position of rearrangement sites of Ret in papillary thyroid
carsinomas. The extracellular part of the Ret is not in scale. From Airaksinen et al. (1999) by permission
of Academic Press, copyright © 1999.
Due to an alternative splicing the Ret
protein is expressed as two major isoforms
of 1072 and 1114 amino acids (Tahira et al.
1990). The intracellular domain of Ret
contains 14 tyrosine residues, and the longer
isoform has two extra tyrosines at the carbon
terminus. Gain of function and loss of
function mutations in the Ret gene lead to
different syndromes, MEN 2 and HSCR,
respectively (for reviews, see Pasini et al.
1996; Edery et al. 1997).
Extensive studies have recently
elucidated the principles of several RTK
signal transduction pathways; following
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dimerization and autophosphorylation of
receptors, src homology 2 (SH2) domain
containing proteins are recruited to the
phosphorylated tyrosine residues (Y) and
activated by various mechanisms (for
review, see Klesse and Parada 1999). Since
Ret ligands have only recently been
identified (Lin et al. 1993; Kotzbauer et al.
1996), earlier studies have used either
papillary thyroid carcinoma (PTC)-Ret
oncogenes (Pasini et al. 1996) or an
epidermal growth factor receptor (EGFR)-
Ret chimera as a source of activated Ret to
study its signal transduction pathways
(Santoro et al. 1994). Autophosphorylation
of Ret generates docking sites for various
signaling effectors; Y905 is known as a
docking site for Grb7/Grb10 (Pandey et al.
1995; Pandey et al. 1996), Y1015 for
phospholipase Cγ (PLCγ) (Borrello et al.
1996), while Y1062 binds both enigma and
the adaptor protein Shc (Asai et al. 1996;
Arighi et al. 1997; Lorenzo et al. 1997;
Ohiwa et al. 1997; Durick et al. 1998;
Ishiguro et al. 1999). In addition, Y1096, a
tyrosine residue specific to the long isoform
of Ret, is a docking site for Grb2 (Liu et al.
1996; Alberti et al. 1998). Binding of these
effector proteins to specific tyrosine residues
induces several signaling pathways typical
of the RTK. These are phosphatidylinositol
3-kinase (PI3-K) (Santoro et al. 1994; van
Weering and Bos 1997), Ras-MAPK (Worby
et al. 1996; Ohiwa et al. 1997), PLCγ
(Borrello et al. 1996), and c-Jun NH2-
terminal protein kinases (JNK) (Chiariello et
al. 1998) dependent pathways. In addition,
Ret has been recently shown to interact with
Crk and Nck, which are molecules
containing SH2-domains (Bocciardi et al.
1997) and to activate the cAMP-responsive
element binding protein (CREB)- or Jun–
mediated gene expression (Xing et al. 1998).
Naturally occurring mutations in the
Ret gene have served as tools to dissect the
intracellular signal pathways activated by the
Ret kinase. In comparison, much less is
known about exact intracellular signaling
pathways triggered by the GDNF family
members when they activate Ret. Both
GDNF and NRTN are known to activate the
MAPK signaling pathway in cultured
sympathetic neurons (Kotzbauer et al. 1996).
In addition, stimulation by GDNF of the
human neuroepithelioma cell line SK-N-MC
transfected with Ret results in PI3-K
activation and PI3-K dependent formation of
lamellipodia, i.e. cell surface protrusions that
are implicated in neuritogenesis (van
Weering and Bos 1997). GDNF and NRTN
have also been shown to activate PI3-K in
rat superior cervical ganglion neurons
(Creedon et al. 1997). More recently PI3-K
activation was shown to be required for
GDNF induced differentiation of
dopaminergic neurons (Pong et al. 1998) as
well as for GDNF, NRTN and PSPN
mediated motoneuron survival (Soler et al.
1999). Recently Trupp et al. (1999) reported
that GDNF induces activation of MAPK and
PI3-K/Akt pathways, increases CREB
protein phosphorylation and c-fos expression
in a motoneuron-derived cell line.
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2.5.2. Mechanisms of GDNF family
signaling
The traditional model of GDNF family
signaling proposes quite a stringent division
of labor. According to this view GFRα
receptors bind ligands with high affinity,
whereas the signaling receptor Ret can not
bind ligands in the absence of
GFRα components (for review, see
Airaksinen et al. 1999). However, recently
Eketjäll et al. (1999) proposed the existence
of two distinct binding sites for GDNF, one
formed by GFRα1 alone and another formed
by a pre-associated GFRα1-Ret complex.
They reported that several GDNF mutants,
which failed to bind GFRα1, retained the
ability to bind and activate Ret at normal
levels. Although GFRα1 binding of these
mutans was impaired, they still required
GFRα1 for Ret activation. The data
suggested that GDNF does not initiate
receptor complex formation, but rather
interacts with a preassembled GFRα1-Ret
receptor complex. However, in contrast to
this view idea Tansey et al. (2000) suggested
recently that Ret and GFRα coreceptors are
not preassociated in vivo in the absence of a
ligand, but become associated after
formation of the GDNF family ligand-GFRα
complexes.
Surprisingly, the GFRα receptors are
not always coexpressed with Ret, and they
are much more widely distributed in several
areas of the nervous system (Golden et al.
1998; Naveilhan et al. 1998; Kokaia et al.
1999). Various levels of GFRα1 and GFRα2
are expressed without Ret in many brain
regions, e.g. the hippocampus and neocortex
(Trupp et al. 1997; Golden et al. 1998; Yu et
al. 1998; Kokaia et al. 1999). Based on the
pronounced differences between the
expression patterns of GFRα receptors and
that of Ret, it has been suggested that there
are multiple mechanisms by which Ret and
the GFRα receptors can mediate the effects
of the GDNF family members (Trupp et al.
1997; Yu et al. 1998). First, Ret may interact
with GFRα receptors expressed in the same
cells (in cis). Second, Ret may interact with
the GFRα receptors located in the adjacent
cells (in trans). For example, in the
peripheral nervous system Schwann cells are
a rich source of GDNF and GFRα1, and
both are dramatically upregulated after nerve
lesion (Naveilhan et al. 1997; Trupp et al.
1997). In this system GFRα1 is suggested to
function in trans to capture and present
soluble GDNF for regenerating motoneurons
expressing Ret (Naveilhan et al. 1997; Trupp
et al. 1997). This mode of action is further
supported by the observation that GDNF can
activate Ret when GFRα1 is provided in
soluble form or immobilized on agarose
beads (Treanor et al. 1996; Yu et al. 1998).
Recently, Tansey et al. (2000) reported that
activation of Ret in cis is a significantly
more efficient mechanism for eliciting
activation of signal pathways downstream of
Ret and the bioactivity of Ret, as compared
to in trans activation of Ret by the soluble
GFRα1 coreceptor. Their results indicate
that binding of GDNF family ligands to cis-
expressed GFRαs and subsequent interaction
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with Ret induce recruitment of the receptor
complex to lipid rafts, which is of
fundamental importance to GDNF family
signaling (Tansey et al. 2000).
Recently two groups reported the
existence of a novel signaling mechanism
mediated by GFRα1 independently of Ret
(Poteryaev et al. 1999; Trupp et al. 1999).
This is in line with the proposed existence of
two distinct binding sites for GDNF, one
formed by a pre-associated GFRα1-Ret
complex and another formed by GFRα1
alone (Eketjäll et al. 1999). Trupp et al.
(1999) reported that GDNF promoted
biochemical and biological changes in a cell
line expressing high levels of GFRα1, but
not Ret. GDNF treatment induced GFRα1-
associated Src-like kinase activity, rapid
phosphorylation of CREB and upregulation
of c-fos mRNA. Poteryaev et al. (1999)
demonstrated GDNF dependent
phosphorylation of MAPK, CREB and
PLCγ in sensory neurons of Ret-deficient
mice. The exact mechanisms how GFRα1
activates the Src family are not established,
but it has been suggested that a
transmembrane adaptor protein links GFRα1
and Src family kinases (Trupp et al. 1999).
Although there is no in vivo evidence, it was
suggested that Ret-independent signaling
may include acute plasticity-related
responses, changes in gene expression and
cell survival (Poteryaev et al. 1999; Trupp et
al. 1999).
2.5.3. Role of other trophic factors in the
signaling of the GDNF family
Recently, Krieglstein et al. (1998b)
showed that GDNF requires TGF-β for
exerting its full neurotrophic potential on a
variety of cultured neurons including
peripheral autonomic, sensory and midbrain
dopaminergic neurons. Interestingly, TGF-β
was not required for the GDNF-dependent
survival of cultured motoneurons
(Krieglstein et al. 1998b). The neurotrophic
effects of GDNF were abolished by adding
antibodies that neutralized endogenous TGF-
β (Krieglstein et al. 1998b). The synergistic
action of TGF-β and GDNF was suggested
to involve the protection of GPI-linked
receptors as shown by the restoration of their
trophic effects after phosphatidylinositol-
specific phospholipase C-mediated
hydrolysis of GPI-anchored GFRα
(Krieglstein et al. 1998b). The synergistic
effects of GDNF and TGF-β on survival of
ciliary ganglionic neurons were mediated by
PI-3 kinase, since they were abolished by
wortmannin which is a selective inhibitor of
this enzyme (Krieglstein et al. 1998b). TGF-
β has been shown to have synergistic
survival-promoting effects on ciliary
ganglionic neurons with the ciliary
neurotrophic factor and the neurotrophins
(Krieglstein et al. 1998a). More recently
Schober et al. (1999) suggested that
endogenous TGF-β is essential for
permitting the neurotrophic effect of GDNF
in vivo. They showed that GDNF rescues
target-deprived sympathetic spinal cord
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neurons but requires TGF-β as cofactor
(Schober et al. 1999). The significance of
TGF-β was confirmed by the fact that
neutralization of endogenous TGF-β by
blocking antibodies abolished the
neuroprotective effect of GDNF (Schober et
al. 1999). Despite the progress in the field,
the mechanism of action and the
physiological significance of TGF-β in
GDNF-induced Ret signaling are currently
unknown. The survival-promoting effect of
GDNF on axotomized corticospinal neurons
in vivo is mediated by an endogenous brain-
derived neurotrophic factor (BDNF) (Giehl
et al. 1998). However, the exact mechanism
of a trophic cross-talk between GDNF and
BDNF in the maintenance of lesioned
corticospinal neurons remains unclear (Giehl
et al. 1998).
2.6. Effects of the GDNF family on
different neuronal populations and non-
neuronal cells
The GDNF family comprises a
multifunctional group of neurotrophic
factors with prominent effects on many
populations of neurons and nonneuronal
cells. Herein only those cell populations
which have received extensive experimental
attention are described.
2.6.1. Midbrain dopaminergic neurons
GDNF exhibits potent survival-
promoting effects on midbrain dopamine
neurons both in culture (Lin et al. 1993) and
in vivo after toxic (Hoffer et al. 1994; Sauer
et al. 1995; Tomac et al. 1995; Gash et al.
1996; Choi-Lundberg et al. 1998; Rosenblad
et al. 2000b) and mechanical (Beck et al.
1995) insults. Consistent with these findings
GDNF is retrogradely transported to the
substantia nigra after injection into the
striatum (Tomac et al. 1995). The
pharmacological effects of GDNF on
midbrain dopaminergic neurons have been
studied in several animal models both in
rodents and nonhuman primates (for
reviews, see Lapchak et al. 1997; Grondin et
al. 1998). Due to its potent effects it is
considered as a drug candidate for the
treatment of Parkinson’s disease. Like
GDNF, also NRTN has survival-promoting
effects on dopaminergic neurons in vitro
(Horger et al. 1998), and is expressed in the
developing and adult nigrostriatal system
(Choi-Lundberg, Bohn, 1995; Widenfalk et
al. 1997; Horger et al. 1998). In vivo NRTN
has been shown to exert neuroprotective
effects in the 6-hydroxydopamine (6-
OHDA) lesion model (Horger et al. 1998;
Rosenblad et al. 1999a; Rosenblad et al.
1999b). However, there seems to be
important differences between the effects of
GDNF and NRTN on developing and adult
substantia nigra dopaminergic neurons;
GDNF has wider survival, neuritogenic and
hypertrophic effects as compared to the
selective survival-promoting effects of
NRTN (Åkerud et al. 1999; Rosenblad et al.
1999b). This may partially be explained by
the observation that the effects of NRTN and
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GDNF on dopamine neurons appear to be
mediated by GFRα1, the preferred
coreceptor for GDNF (Cacalano et al. 1998).
Also the more recently discovered members
of the GDNF family, PSPN and ARTN have
shown some survival-promoting effects on
cultured substantia nigra dopaminergic
neurons (Baloh et al. 1998a; Milbrandt et al.
1998). This year, Rosenblad et al. (2000a)
showed that lentiviral gene transfer of
ARTN into the midbrain promoted the
survival of nigral dopamine neurons after an
intrastriatal 6-OHDA lesion.
2.6.2. Spinal motoneurons
GDNF increases choline
acetyltransferase (ChAT) activity in
embryonic motoneurons (Zurn et al. 1994)
and is perhaps the most potent factor in
rescuing developing motoneurons from
naturally occurring or axotomy-induced cell
death (Henderson et al. 1994; Oppenheim et
al. 1995). It rescues adult motoneurons from
avulsion-induced cell death (Li et al. 1995),
attenuates the lesion-induced decrease of
ChAT immunoreactivity in the nucleus of
the facial nerve (Yan et al. 1995), and
enhances sciatic nerve regeneration after
crush injury (Naveilhan et al. 1997). It is
also retrogradely transported in motoneurons
(Yan et al. 1995). Recently it was reported
that synapse elimination is substantially
delayed in transgenic mice with muscle-
specific overexpression of GNDF (Nguyen
et al. 1998). In addition, GDNF is suggested
to enhance transmitter release at the
immature mammalian neuromuscular
junction (Ribchester et al. 1998).
NRTN and PSPN also promote the
survival of developing motoneurons in vitro
(Klein et al. 1997; Milbrandt et al. 1998). In
addition, PSPN rescues motoneurons from
axotomy-induced cell death in the neonate
rat (Milbrandt et al. 1998). NRTN, like
GDNF, increases ChAT activity in postnatal
motoneurons, induces neurite outgrowth in
the spinal cord, and potentially protects
motoneurons from chronic glutamate
mediated degeneration (Bilak et al. 1999). In
contrast, PSPN has no effects on mature
motoneurons (Bilak et al. 1999). Recently,
Soler et al. (1999) reported that GDNF,
NRTN and PSPN promote the survival of
chicken motoneurons in vitro, most probably
through the PI-3 kinase pathway. They also
reported that Ret, GFRα1, GFRα2, GFRα4,
but not GFRα3 mRNAs are expressed in
embryonic chick spinal cord (Soler et al.
1999). The expression of GFRα1 and
GFRα2 receptor mRNAs in the ventral horn
of the spinal cord in rat embryos had been
reported earlier (Yu et al. 1998), as well as
the expression of GFRα4 mRNA in the
embryonic chicken spinal cord (Thompson
et al. 1998). Both Ret and GFRα1 mRNAs
are upregulated in spinal motoneurons after a
transection or crush injury of the sciatic
nerve (Naveilhan et al. 1997; Trupp et al.
1997). Further, transection upregulates
GDNF and GFRα1 mRNAs in the distal
nerve segment of the sciatic nerve (Trupp et
al. 1997).
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2.6.3. Enteric neurons
Loss of function mutations in the
human Ret gene causes congenital
dysgenesis of the enteric nervous system
known as HSCR (Edery et al. 1994; Romeo
et al. 1994). Also mice deficient in Ret lack
the enteric ganglia posterior to the proximal
stomach (intestinal aganglionosis)
(Schuchardt et al. 1994; Durbec et al.
1996b). Targeted mutations of GDNF and
GFRα1 genes in mice result in phenotypes
that are remarkably similar to that of Ret-
deficient mice with severe defects of enteric
innervation (Moore et al. 1996; Pichel et al.
1996; Sanchez et al. 1996; Cacalano et al.
1998; Enomoto et al. 1998). Also, mice
lacking NRTN (Heuckeroth et al. 1999) have
certain defects in the enteric nervous system
although the phenotype of these mice is not
as dramatic as that of the Ret-, GDNF- or
GFRα1-deficient mice. These findings are
consistent with the expression of Ret,
GFRα1, GFRα2, GDNF and NRTN mRNAs
in the developing enteric nervous system
(Pachnis et al. 1993; Durbec et al. 1996b;
Suvanto et al. 1996; Widenfalk et al. 1997;
Golden et al. 1999).
Although genetic studies have
established the critical role of Ret-mediated
signaling in the development of the
mammalian enteric nervous system, the
mechanism of action in vivo is not well
known. Recently, Natarajan et al. (1999)
showed that multipotential enteric
progenitors are capable of colonising
efficiently both wild-type and Ret-deficient
aganglionic bowel in organ culture. Based
on these findings, they suggested that Ret
functions cell-autonomously in enteric cells
derived from the neural crest (Natarajan et
al. 1999). Recently, Taraviras et al. (1999)
reported that GDNF and NRTN promote in
vitro survival of enteric neurons, as well as
the survival, proliferation, and differentiation
of multipotential enteric nervous system
progenitors present in the gut of rat embryos.
They also showed that a subpopulation of
enteric neural crest-derived cells undergoes
apoptotic cell death in the foregut of
embryos lacking the Ret receptor. Consistent
with these results Hearn et al. (1998)
proposed that GDNF promotes proliferation
of the migratory enteric neural precursor cell
population once the cells have entered the
gut, and is especially crucial for the
differentiation of these cells into
nonmigrating, nonproliferating enteric
neurons. Also Heuckeroth et al. (1998)
showed that GDNF and NRTN, but not
PSPN, potently support the survival and
proliferation of immunopurified gut neural
crest precursor cells in vitro. The nature and
age dependence of the effects of GDNF on
the in vitro development of the precursors of
enteric neurons and glia in rat has also been
analysed. GDNF stimulates the proliferation
of an early precursor common to enteric
neurons and glia, and exerts a neurotrophic,
but not a mitogenic effect on the neuronal
progenitors, but does not maintain the glial
progenitor cells (Chalazonitis et al. 1998).
16
2.6.4. Autonomic and sensory neurons
In the peripheral nervous system
GDNF, NRTN and ARTN, but not PSPN,
support the survival of subpopulations of
sensory and autonomic neurons of rodents
and chicks in vitro (Ebendal et al. 1995;
Trupp et al. 1995; Kotzbauer et al. 1996;
Moore et al. 1996; Baloh et al. 1998a;
Milbrandt et al. 1998). Consistent with the
wide effects of the GDNF family on the
developing peripheral nervous system, Ret
protein and mRNA are detected in all
sensory and autonomic ganglia of
developing mice (Pachnis et al. 1993; Nosrat
et al. 1997; Naveilhan et al. 1998; Golden et
al. 1999). Also the GFRα1, GFRα2 and
GFRα3 coreceptors are expressed in sensory
and autonomic ganglia throughout
embryonic development (Baloh et al. 1998b;
Golden et al. 1999). Recently, Lindahl et al.
(2000) reported that during mouse
embryonic development moderate GFRα4
mRNA expression is seen in several
peripheral ganglia, including the sensory
dorsal root and trigeminal as well as the
superior cervical and sympathetic chain
ganglia. However, due to alternative splicing
of the mouse GFRα4, it is not known
whether functional GFRα4 transcripts are
expressed in peripheral neurons. At different
stages of development, populations of
peripheral neurons differ markedly in their
responsiveness to GDNF and NRTN (Forgie
et al. 1999). Recently, it was suggested that
these differences are governed in part by the
relative levels of expression of GFRα
receptors (Forgie et al. 1999). Interestingly,
KCl-induced depolarisation causes a marked
increase in GFRα1 mRNA but a marked
decrease in GFRα2 mRNA in developing
sympathetic, parasympathetic, and sensory
neurons (Doxakis et al. 2000). These
changes are accompanied by increased
responsiveness to GDNF and reduced
responsiveness to NRTN. This provides
evidence for a mechanism of regulation of
the neurotrophic factor responses of
developing peripheral neurons by neuronal
activity. The physiological relevance of the
in vitro effects of the GDNF family on the
survival of the peripheral nervous system
neurons is substantiated by reduction of
sensory, enteric and autonomic neurons in
mice having defects in the GDNF family
members or their receptor components
(Airaksinen et al. 1999; Rosenthal, 1999;
Nishino et al. 1999).
Although genetic studies have
established the critical role of various GDNF
family members for the development of the
peripheral nervous system, less is known
about their importance for mature neurons.
GDNF can prevent the death of axotomized
neonatal sensory neurons (Matheson et al.
1997). Soon after birth, a population of small
nonpeptidergic dorsal root ganglia (DRG)
neurons switch their sensitivity from NGF to
GDNF (Molliver et al. 1997). These isolectin
B4 (IB4)-binding neurons remain sensitive
to GNDF in adulthood. GDNF can prevent
several axotomy-induced changes in these
neurons including changes in GFRα1 and
GFRα2 expression (Bennett et al. 1998;
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Bennett et al. 2000). Recently, Leitner et al.
(1999) reported that both GDNF and NRTN
are retrogradely transported to the somata of
adult rat DRG neurons after injection into
the sciatic nerve, but not to the somata of
sympathetic neurons of the superior cervical
ganglion (SCG) after injection into the eye.
2.6.5. Kidney
Recent data have shown that in
addition to its neurotrophic properties GDNF
regulates morphogenesis of ureteric
branching (for review, see Sariola and
Saarma 1999). GDNF mRNA is expressed in
the condensing pretubular mesenchyme that
surrounds the developing ureteric system
(Suvanto et al. 1996; Sainio et al. 1997). 125I-
labeled GDNF binds to the tips of the
ureteric buds, which express mRNAs for Ret
and GFRα1 (Sainio et al. 1997, Widenfalk et
al. 1997). GDNF is thought to be required
primarily for bud initiation from ureteric
epithelium, since in organ culture it
promotes dose-dependently bud formation
from different parts of the Wolffian duct,
and attracts ureteric branches towards the
source of GDNF (Sainio et al. 1997). GDNF,
combined with mechenchyme-derived
soluble factors, may also induce branching
morphogenesis of ureteric buds in the
absence of direct contact with mesenchymal
tissue (Qiao et al. 1999). Consistent with
these observations GDNF increases cell
motility, dissociation of cell adhesion, and
migration of Ret-transfected renal epithelial
MDCK cells toward a localized source of
GDNF (Tang et al. 1998). Studies with
GDNF-deficient mice (Pichel et al. 1996;
Treanor et al. 1996) and with neutralizing
antibodies to GDNF (Vega et al. 1996) are
also consistent with the idea that GDNF is
necessary for development of the ureteric
bud. GDNF-deficient mice show regularly
renal aplasia (Moore et al. 1996; Pichel et al.
1996; Sanchez et al. 1996). Similarly, Ret-
deficient mice show renal agenesis or severe
dysgenesis (Schuchardt et al. 1994). The
deficits in renal development in mice lacking
GFRα1 closely resemble those found in Ret-
and GDNF-deficient mice (Cacalano et al.
1998; Enomoto et al. 1998). In contrast to
GDNF, which is expressed in the peripheral
mesenchyme of the developing kidney,
NRTN is colocalized with Ret in the
developing epithelial buds (Widenfalk et al.
1997). The physiological role of NRTN in
kidney morphogenesis remains to be
established. However, the fact that NRTN-
deficient mice do not show any defects in
kidney morphogenesis suggests that the role
of NRTN in kidney development may not be
critical (Heuckeroth et al. 1999). Recently,
Mildbrandt et al. (1998) reported that PSPN
at nonphysiological concentrations was able
to promote the branching of ureteric buds.
These results indicate that also PSPN may
possibly act as a renal ramogen and might
form part of a redundant system that would
explain the variability in the kidney
phenotypes in GDNF-deficient mice
(Milbrandt et al. 1998).
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2.6.6. Testis
Recently, Meng et al. (2000) showed
that GDNF, produced by Sertoli cells,
regulates the fate of undifferentiated
spermatogonial cells that include the stem
cells for spematogenesis. They showed that
mice with one GDNF-null allele suffer
depletion of stem cells, whereas transgenic
mice, overexpressing GDNF in
spermatogonia under the influence of a
testis-specific promoter, are infertile and
show accumulation of undifferentiated
spermatogonia (Meng et al. 2000). These
results are in line with temporal and spatial
distribution of GDNF, Ret and GFRα1
mRNA in the testis (Trupp et al. 1995;
Suvanto et al. 1996; Widenfalk et al. 1997;
Hu et al. 1999, Meng et al. 2000). GDNF
mRNA expression in the postnatal testis is
restricted to Sertoli cells (Trupp et al. 1995;
Hu et al. 1999, Meng et al. 2000), whereas
Ret and GFRα1 mRNAs are expressed in a
subset of spermatogonia (Meng et al. 2000).
GDNF, Ret and GFRα1 mRNAs are all
expressed at their highest levels during the
first postnatal week whereafter they are
downregulated (Trupp et al. 1995; Meng et
al. 2000).
Interestingly, NRTN and GFRα2
mRNAs show a complementary expression
pattern in the testis of adult mouse
(Widenfalk et al. 1997; Widenfalk et al.
2000). A NRTN mRNA signal is seen in the
periphery of the seminiferous tubules,
suggesting localization to the Sertoli cells,
whereas GFRα2 is most probably localized
in the germ cells (Widenfalk et al. 1997).
However, the accurate localization of the
mRNA species to different cell types in the
testis of adult mice has still to be done
(Widenfalk et al. 2000). NRTN
overexpressing mice show a phenotype
different from that of GDNF overexpressing
mice (Meng et al. 2000). These mice had
normal fertility and only a transient delay of
spermatogenesis, indicating that the role of
NRTN is not vital or that it can be
substituted for.
Recently Hu et al. (1999) reported that
GDNF stimulates Sertoli cell proliferation in
vitro. This is surprising, since Sertoli cells
do not express detectable levels of GDNF
receptors (Meng et al. 2000). Indeed, Sertoli
cell distribution is unaltered in the testes of
GDNF overexpressing mice, suggesting that
the proliferation of Sertoli cells is not
regulated by GDNF in vivo (Meng et al.
2000). Nonmetastatic testicular tumors were
regularly formed in older GDNF-
overexpressing mice, suggesting that GDNF
is also involved in the pathogenesis of germ
line tumors (Meng et al. 2000).
2.7. Knockouts of GDNF family members
and their receptors
Although biochemical data had
provided evidence of an essential role of
GPI-linked GFRα receptors in the signaling
induced by the GDNF family members, the
in vivo role of these neurotrophic factors
remained controversial until characterization
of the corresponding knockout mice. This
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was partially due to the fact that this was the
first time when a transmembrane RTK was
shown to require a GPI-linked coreceptor for
activation and determination of ligand
specificity. The physiological roles of the
GDNF family members and their receptors
are highlighted by the phenotypes of their
knockout mice (for reviews, see Airaksinen
et al. 1999; Rosenthal 1999; Baloh et al.
2000a). Ret-deficient mice fail to form a
ureteric bud and lack enteric neurons
throughout the digestive tract below the
stomach (Schuchardt et al. 1994). Mice
lacking GFRα1 or GNDF show striking
similarities with Ret-deficient mice in their
phenotypes. Both die soon after birth and
have severe defects in the enteric innervation
and kidney development (Moore et al. 1996;
Pichel et al. 1996; Sanchez et al. 1996;
Cacalano et al. 1998; Enomoto et al. 1998).
In addition, small defects are detected in
sensory, sympathetic and motor nuclei of
these mice, whereas their dopaminergic
neurons seem to develop normally. Despite
the high similarity of phenotypes there are
small differences in, e.g. the sympathetic
ganglia. Ret-deficient mice completely lack
SCG neurons in their normal location,
whereas no change in the number of SCG
neurons was seen in GFRα1-deficient mice,
and only a 30% loss in GDNF-deficient mice
(Durbec et al. 1996a; Moore et al. 1996;
Cacalano et al. 1998; Enomoto et al. 1998).
These similarities support the idea that Ret
functions as a common signaling receptor for
the GDNF family members and that GDNF
acts primarily through GFRα1.
NRTN-deficient mice show defects in
the parasympathetic and enteric nervous
system (Heuckeroth et al. 1999). They are
viable and fertile, but have a dramatically
reduced parasympathetic cholinergic
innervation of the lacrimal and salivary
glands, and a reduced myenteric plexus
innervation (Heuckeroth et al. 1999). Mice
lacking GFRα3 exhibit severe defects in
their SCG, whereas their other ganglia seem
to be normal (Nishino et al. 1999). In the
mutant embryos SCG precursor cells fail to
migrate to the correct position as well as to
innervate the target organs, and undergo
progressive cell death after birth (Nishino et
al. 1999). The subtle defects in SCG of
GDNF-deficient mice (Moore et al. 1996)
suggest that GDNF-GFRα3 interaction may
have some physiological significance in vivo
(Nishino et al. 1999). Similarly experiments
with primary cultures of GFRα1-deficient
mice nodose sensory and dopaminergic
neurons have revealed that these populations
have lost their responsiveness not only to
GDNF but also to NRTN, suggesting
interactions between NRTN and GFRα1
(Cacalano et al. 1998). However, the
physiological significance of these
interactions remains unclear since these
neurons survive in GFRα1-deficient mice
(Cacalano et al. 1998). Despite the progress
made the physiological functions of ARTN,
PSPN and GFRα4 still remain to be solved.
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2.8. The GDNF family and activity-
dependent neuronal plasticity in the brain
Several lines of evidence suggest that,
in addition to their well-established survival
and neurite growth promoting properties, the
GDNF family members may be involved in
activity-dependent neuronal plasticity in a
manner similar to that of neurotrophins (for
review, see Thoenen 1995). First, GDNF
family ligands, as well as their receptors, are
expressed in specific neuron populations of
adult rodent brain, with partially overlapping
patterns (Burazin and Gundlach 1999;
Golden et al. 1998; Kokaia et al. 1999).
Second, GDNF and NRTN, as well as their
receptors are differentially regulated after
various brain insults. For example, kainic
acid, pilocarpine, as well as kindling-evoked
seizures differentially regulate the
expression of GDNF, NRTN, Ret, GFRα1
and GFRα2 mRNAs in several forebrain
structures (Humpel et al. 1994; Schmidt-
Kastner et al. 1994; Trupp et al. 1997; Trupp
et al. 1998; Kokaia et al. 1999). Third,
although the mechanisms regulating the
neuronal synthesis and release of GDNF
family ligands are poorly known, there is
evidence suggesting that synthesis and
release of GDNF can be regulated by
numerous factors. Recently, Verity et al.
(1998) reported that synthesis and secretion
of GDNF in cells of glial and neuronal origin
are differentially regulated in response to
growth factors, cytokines and
pharmacophores (e.g. fibroblast growth
factors and interleukin-1β). Consistent with
these observations, Krieglstein et al. (1998)
showed that cholinergic stimulation
regulates calcium-dependently the release of
GDNF from chromaffin granules. Fourth,
GDNF can regulate neurotransmitter
production and release in several neuron
populations, for example, in dopaminergic
and serotonergic neurons (Beck et al. 1996;
Pothos et al. 1998; Feng et al. 1999). It may
also increase spontaneous transmitter release
at the neuromuscular junction of neonatal
mouse (Ribchester et al. 1998).
2.9. Neural control of penile erection
Penile erection is predominantly a
nerve-mediated vascular event (for review,
see Andersson and Wagner 1995). The
pelvic plexus is the main source of penile
erection-inducing nerve fibers, and it
innervates also the internal reproductive
organs, the lower urinary tract and the lower
bowel (Dail 1996; Keast 1999). It is a
collection of postganglionic nerve cell
bodies that receive their preganglionic
parasympathetic input via the pelvic nerves
and preganglionic sympathetic input via the
hypogastric nerves. The parasympathetic
pelvic nerves are of primary importance for
the smooth muscle relaxation required for
penile tumescence, although the sympathetic
hypogastric nerves play a role as well, the
importance of which varies between
mammalian species (Eckhard 1876; Langley
and Anderson 1895; Sjöstrand and Klinge
1979; Dail et al. 1986; Klinge and Sjöstrand
1994). In the rat the hypogastric nerve is
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preganglionic to about 20% of penile
neurons in the pelvic plexus (Dail et al.
1985). In the last two decades, the rat has
largely replaced the dog as an animal model
to study the physiology of penile erection.
One of the reasons for this is that the pelvic
plexus of the rat consists of a single bilateral
large ganglion, called the MPG, and small
accessory ganglia, the vesicodeferential
ganglia (Quinlan et al. 1989; Dail 1996;
Keast 1999).
The essential role of nitric oxide (NO)
as the principal neurotransmitter of the
erection-inducing nerves has been well
established in several mammals (Burnett et
al. 1992; Klinge and Sjöstrand 1994). It
diffuses into the smooth muscle cells of the
penile arteries and the cavernous spaces,
where it increases the synthesis of cGMP
and decreases cytosolic Ca2+, thus inducing
relaxation (Burnett 1995). The occurrence of
vasoactive intestinal peptide (VIP)–
immunoreactive (IR) nerves in penile tissues
has also been identified in different species
(for references, see Klinge and Sjöstrand
1994; Andersson and Wagner 1995). VIP
induces inconsistent and tachyphylactic
relaxation of the isolated penile artery,
corpus cavernosum and retractor penis
muscles from several mammals (Sjöstrand et
al. 1981; Willis et al. 1983). Its possible
significance in the induction of penile
erection is so far unsolved. In addition to
VIP, several other peptides, e.g.
neuropeptide Y (NPY) and calcitonin gene-
related peptide (CGRP), have been
demonstrated to occur in the nerves of penile
vessels and corporal smooth muscle
(Andersson and Wagner 1995). However,
their roles in the physiological regulation of
erection are, like that of VIP, not fully
established.
Consistent with the idea that the
nNOS-containing penile neurons are
cholinergic, vesicular acetylcholine
transporter (VAChT)- and NOS-IR terminals
show coinciding profiles in the rat corpus
cavernosum (Hedlund et al. 1999). The
VAChT is a small carrier protein, which
transports newly synthesized acetylcholine
into presynaptic and prejunctional vesicles,
and its immunohistochemical visualization
has suggested it to be a specific marker of
cholinergic nerves (Arvidsson et al. 1997).
Cholinergic transmission may contribute to
penile tumescence and erection at least via
three distinct mechanisms, all of which
counteract the effects of noradrenaline: First,
acetylcholine may activate prejunctional
muscarinic receptors on adrenergic nerve
terminals and thus reduce the release of
noradrenaline (Klinge and Sjöstrand 1977,
1994; Blanco et al. 1988). Second,
acetylcholine may release relaxant factors
from the endothelium by activation of the
endothelial muscarinic receptors (Andersson
and Wagner 1995). However, the variable
effects of muscarinic antagonists, e.g.
atropine, on penile erection in numerous
studies with different species suggest that
cholinergic muscarinic effects play no
significant role in the induction of erection.
In most studies atropine has been completely
ineffective, whereas in some animal studies
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Figure 2.4. Neural control of penile erection. The diagram concisely presents the central and peripheral
neural pathways involved in the control of penile erection. Penile tumescence (T) is caused by nitrergic
neurons running in the cavernous nerve. Detumescence (D) is caused by noradrenergic nerves originating
mainly in the paravertebral sympathetic chain ganglia (dotted lines). + indicates synaptic excitatory, and –
synaptic inhibitory mechanisms. From de Groat and Steers (1988) by permission of Lippincott Williams &
Wilkins, copyright © 1988 (http://www.lww.com).
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atropine reduced pelvic- or cavernous nerve-
evoked erections (for references, see de Groat
and Booth 1993). Third, cholinergic nicotinic
effects, however, play a most essential role in
the induction of penile erection.
Acetylcholine released from preganglionic
nerve terminals, and possibly also from
adjacent nerves, excites the NO releasing
neurons (Klinge et al. 1988; Klinge and
Sjöstrand 1994). Accordingly, ganglion-
blocking drugs such as hexamethonium,
almost invariably cause impotence.
Figure 2.4. summarizes the neural
pathways controlling penile erection. Normal
erection requires also participation of the
lumbosacral somatic system which to a
variable extent contracts the ischiocavernosus
and bulbocavernosus muscles, and thereby
contributes to the venous compression (de
Groat and Booth 1993). The dorsal nerve of
the penis carries along the pudendal nerve
sensory fibers which form the afferent
pathway of the reflexogenic erection (de
Groat and Booth 1993). In contrast to
psychogenic erections, which are initiated by
supraspinal centers in response to various
stimuli, reflexogenic erections are mediated
by a sacral spinal pathway, and are preserved
in patients with spinal cord injuries above the
sacral segments (Bors and Comarr 1960;
Comarr 1970). Psychogenic erections seem to
be in part mediated via sympathetic
pathways, i.e. the hypogastric nerves, since
erectile function is preserved in some patients
with suprasacral spinal cord lesions (Bors and
Comarr 1960; Comarr 1970). Although
normal erection requires participation of
parasympathetic, sympathetic and
lumbosacral somatic parts of the peripheral
nervous system, defects in any of them do not
fully exclude erectile function (Andersson
and Wagner 1995).
2.10. Neurotrophic factors and the
innervation of the penis
While the immediate functioning of the
erection inducing neurons is relatively well
characterized, very little is known about the
neurotrophic factors controlling their survival
and/or regeneration. In the rat model
(Quinlan et al. 1989), cavernous nerve
grafting can be successfully used to restore
potency after surgical injury (Quinlan et al.
1991). Cavernous nerve regeneration is
significantly enhanced if appropriate grafting
material is combined with NGF (Burgers et
al. 1991). NGF mRNA is expressed in the rat
penis at levels consistent with its expression
in other peripheral tissues (Te et al. 1994).
Basic fibroblast growth factor (bFGF) is
expressed in the penis at levels far in excess
of NGF and seems to mediate the neurite
outgrowth promoting activity of a penis
extract in PC12 cell bioassay (Te et al. 1994).
Since bFGF has both angiogenic and
neurotrophic activities it may have a
significant role in the physiology of erection
(Te et al. 1994). Consistent with these results
Tuttle et al. (1994) reported that NGF, bFGF
and ciliary neurotrophic factor (CNTF)
increase survival of MPG neurons cultured
from female adult rat. Whether these factors
increase survival of MPG neurons cultured
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from male rats is not currently known.
Dahiya et al. (1999) compared mRNA
expression of several growth factors in penile
tissues from young and old rats. TGF-β1
expression was increased, whereas expression
of NGF and TGF-β3 was decreased in penile
tissues of old rats. There was no change in
the expression of insulin-like growth factor
(IGF)-I or TGF-β2 (Dahiya et al. 1999). In
penises of diabetic rats there was no
significant change in the expression of IGF-I,
NGF or TGF-β1 compared to normal adult
rat penises (El-Sakka et al. 1999). In contrast
to diabetes, neurotomy of the cavernous
nerves seems to induce changes in the
expression of growth factors. After unilateral
cavernous nerve neurotomy IGF-I mRNA
expression in rat penis showed a significant
increase at three months (Jung et al. 1999).
Similarly TGF-β2 expression was
significantly decreased at one month but was
nearly recovered at 3 months (Jung et al.
1999). NGF mRNA expression in the rat
penis was not regulated by unilateral or
bilateral cavernous nerve neurotomy (Jung et
al. 1999).
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3. AIMS OF THE STUDY
The aim of this work was to study the possible role of the GDNF receptor components, Ret
and GFRα1, on neuronal plasticity following epileptic seizures and to elucidate in vivo functions
of GFRα2. There was also an interest in investigating whether some of the GDNF family
members might regulate the development and/or functioning of penile erection-inducing neurons.
The specific aims were:
- To study whether the expression of the mRNAs for the GDNF receptors Ret and
GFRα1 is changed in adult rat brain in response to neuronal activity by applying the
kainate-induced seizure model.
- To assess the in vivo importance of the coreceptor GFRα2 and its physiological ligand
specificity using mice lacking a functional GFRα2 receptor.
- To investigate whether NRTN and GDNF meet some of the basic requirements for
being neurotrophic factors for penile erection-inducing and penile afferent neurons.
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4. MATERIALS AND METHODS
The methods used have been described in
more detail in the respective
communications.
4.1. Animals (I-IV)
Male adult Wistar rats (nine to twelve
weeks old) were used throughout the
experiments (I, III and IV). GFRα2-/- and
wild-type mice were littermates from
heterozygote mating in the hybrid 129/Sv x
C57BL/6 backround (II and III). The animals
were kept on a normal day and night cycle
and were given free access to food and water.
The experimental protocols were approved by
the Committee for Animal Experiments of
the Faculty of Science of the University of
Helsinki.
4.2. Sample tissues (I-IV)
The tissues were treated as described in
I-IV. In experiments where embryonal tissues
were used (II-IV), the animals were mated
overnight and the next day was regarded as
embryonal day 0 E(0).
4.3. Drugs and recombinant proteins (I-IV)
The rats were anaesthetized with a s.c.
injection of a combination of midazolam (0.8
mg/kg, Roche, Basel, Switzerland) and a
mixture of fentanyl citrate (0.25 mg/kg) and
fluanisone (8 mg/kg) (Janssen Pharmaceutica,
Beerse, Belgium) (III and IV) or a
combination of ketamine (105 mg/kg i.p.,
Parke-Davis, Solna, Sweden) and xylazin (6
mg/kg i.m., Bayer AG, Leverkusen,
Germany), whereas the mice were
anaesthetized with Avertin (II). Kainate (12
mg/kg s.c.) and dizocilpine maleate (MK-
801, 1 mg/kg s.c.) which were both obtained
from Tocris Cookson (Ballwin, MI, USA),
whereas cycloheximide (8 mg/kg s.c.) and
pentylenetetrazole [metrazole, 6,7,8,9-
tetrahydro-5H-tetrazolo-(1,5a)azepine, 50
mg/kg s.c.] were obtained from Sigma (St.
Louis, MO, USA) (I). Recombinant NRTN,
GDNF and NGF were obtained from
PeproTech (Rocky Hill, NJ, USA) (II and
III). Rat recombinant GDNF produced by
expressing the cDNA in baculovirus-infected
insect cells was kindly provided by Cephalon
Inc. ( West Chester, PA, USA) (II and IV).
4.4. RNA preparation and Northern blot
analysis (I-IV)
Total RNA was isolated from frozen
samples using the acid guanidinium
thiocyanate-phenol-chloroform extraction
method (I-IV) (Chomczynski and Sacchi
1987). Poly-A mRNA was purified with an
Oligotex mRNA Midi Kit (Qiagen, Hilden,
Germany) (III and IV). RNA samples were
fractionated on a 1.2% agarose-formaldehyde
gel and transferred to a nylon membrane
(Magna, MSI, Westborough, MA, USA).
Following the transfer the membranes were
fixed by UV irradiation, prehybridized, and
hybridized with 32P-labeled cDNA probes at
65°C in 1 M NaCl, 1% sodium dodecyl
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sulfate, 10% dextrane sulfate and 100 µg/ml
sonicated herring sperm DNA. After high
stringency washes (0.1 x saline-sodium
citrate (SSC), 0.5% sodium dodecyl sulfate at
55-63°C) the blots were exposed either to X-
ray film or a Fujifilm BAS-1500 bio-imaging
analyser (Fuji Photo Film, Tokyo, Japan). To
compare the relative levels of mRNA in
different lanes, the filter was rehybridized
with a glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) probe (II-IV).
4.5. RT-PCR and construction of probes
(I-IV)
Probes were constructed by RT-PCR as
described by Suvanto et al. (1996, 1997).
Briefly 5 µg of total RNA purified from rat
brain was incubated with random primers for
10 min at 70°C and flash frozen in liquid
nitrogen. After thawing 400 units of
Superscript II-reverse transcriptase (Life
Technologies, Gaithersburg, MD, USA) were
added and the reaction mixture was incubated
for 1 hr at 37°C. The PCR was performed in
50 µl containing 2 µl of reverse transcription
mixture as a template with 100 pmol of each
primer, using AmpliTag polymerase. The
reaction mixture was heated at 95°C for 5
min before the enzyme was added. All
reagents used in the PCR were purchased
from Perkin Elmer (Roche Molecular
Systems, Branchburg, NJ, USA). The
products were analyzed by gel
electrophoresis in 1-2% agarose gel with
ethidium bromide staining. The fragments
were excised from the gel and purified with
Wizard PCR purification kit (Promega). After
purification, the DNA fragments were ligated
to pGEM-T (Promega). The identity of the
cloned fragments was verified by direct
sequencing with a Pharmacia A.L.F.
automatic DNA sequencer. The list of the
probes used in the in situ hybridization and
Northern hybridization are presented in Table
4.1.
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Table 4.1. Probes used in in situ hybridization and Northern hybridization.
Probe Size/Vector Nucleotides Accession number Used in
Rat GDNF  (1,2) 388bp in pBSKII+ 52-688 L15305 IV
Mouse NRTN  (1,2) 587bp in pcDNA3 349-936 U78109 III,IV
Rat Ret  (1) 179bp in pGEMT 21-200 U22514 III,IV
Mouse Ret  (2) 3348bp in in pBSKII+ 1-3348 X67812 I
Mouse Ret  (1) 684bp in pGEM5Z 2534-3217 X67812 I
Rat GFRα1  (1,2) 745bp in pGEMT 294-1039 U59486 I, III
Mouse GFRα1  (2) 777bp in pT7T3D-Pac 1-777 AF012811 II
Rat GFRα2  (1) 172bp in pGEMT 85-257 AF003825 III
Mouse GFRα2  (2) PCR fragment 1-524 NM_008115 II
Mouse GFRα2 exon 1  (1) 424bp in pT7T3 1-424 AA0478808 II
Rat GFRα3  (1) 404bp in pBSKII+ 81-489 AF184920 III
Rat GAPDH  (2) 812bp in pGEMT 137-949 X02231 II-IV
In situ hybridization (1)
Northern hybridization (2)
4.6.
 In situ hybridization (I-IV)
The 35S-UTP-labeled sense and
antisense RNA probes were prepared, and the
in situ hybridization of sections was
performed according to Wilkinson and Green
(1990) with some modifications. Briefly,
plasmids containing cDNAs were linearized
and antisense and sense probes were
generated by in vitro transcription. The
probes were purified using Sephadex G-50
NICK columns (Amersham Pharmacia
Biotech, Buckinghamshire, UK), ethanol
precipitated, air-dried, and dissolved in the
hybridization mixture containing 1 M
dithiothreitol DTT (Promega). The probes
were diluted to a final activity of 30-40 x 103
counts per min/µl. The paraffin sections were
deparaffinized in xylene, rehydrated, fixed in
4% (wt/vol) paraformaldehyde (PFA) in
phosphate buffered saline (PBS), rinsed in
PBS, and treated with proteinase K (20µg/ml,
Sigma) for 5-15 minutes, postfixed with 4%
PFA in PBS, acetylated, dehydrated, air-
dried, and hybridized with a cRNA probe
overnight at 52°C. Prehybridization (1-1.5 hr
at 52°C) with a hybridization mixture lacking
the probe was performed. All the
cryosections were treated as paraffin sections
with the exception of the proteinase K
treatment (1 µg/ml). After hybridization, the
sections were rinsed at high stringency for 30
minutes, treated with RNase A (Boehringer
Mannheim, Mannheim, Germany),
dehydrated, and air dried. Sections were
dipped in emulsion (Kodak NTB-2), and
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exposed for 3 to 5 weeks. Subsequently the
slides were developed (Kodak D19
developer), counterstained with Harris
hematoxylin and mounted in Permount
(Fisher Chemical, Zürich, Switzerland).
4.7. Retrograde tracing of penis-projecting
neurons (III and IV)
The rats were anaesthetized with a s.c.
injection of a combination of midazolam (0.8
mg/kg, Roche) and a mixture of fentanyl
citrate (0.25 mg/kg) and fluanisone (8
mg/kg), whereafter 10 µl of a 4% aqueous
solution of Fluoro-Gold (FG; Fluorochrome,
Denver, CO, USA) was injected into the
corpora cavernosa. After 10 days the rats
were sacrificed under anaesthesia by
transcardial perfusion with phosphate-
buffered saline (PBS; 0.1 M sodium
phosphate/0.14 M NaCl/2.6 mM KCl, pH
7.5) (50 ml) followed by fresh 4%
paraformaldehyde (PFA; 200 ml) in PBS.
MPGs and DRGs from level S1 were
dissected and postfixed for 1.5-2 hours at
room temperature. After fixation all samples
were rinsed in PBS and processed for paraffin
sectioning at 7 µm on Super Frost Plus slides
(Menzel-Gläser, Braunschweig, Germany).
4.8. Iodination of proteins (III and IV)
Rat recombinant GDNF produced by
expressing the gene in baculovirus-infected
insect cells was radioiodinated with the
Bolton & Hunter reagent (IV) (Bolton and
Hunter 1973). GDNF protein (10 µg) in 20 µl
of 0.1 M borate buffer, pH 8.5, was placed in
dried 2mCi (1Ci=37GBq) of 125I-labeled
Bolton-Hunter reagent (Amersham
Pharmacia Biotech), and the reaction mixture
was incubated at 4ºC for 15 minutes. The
reaction was stopped by adding 0.5 ml of a
solution containing 0.2 M glycine in 0.1 M
borate buffer, pH 8.5. Human recombinant
NRTN produced in E. coli was radioiodinated
by the lactoperoxidase method (III)
(Marchalonis 1969). The following
ingredients were mixed and kept at room
temperature for 18 minutes in a final volume
of 50 µl: 1 mCi Na125I (Amersham Pharmacia
Biotech), 10 µg NRTN protein, 0.5 U
lactoperoxidase (Sigma), 2 µl 0.03% H2O2
and 0.1 M sodium phosphate buffer, pH 6.0.
After the first 9 minutes of incubation, an
additional 2 µl of H2O2 was added. The
reaction was terminated by adding 3 volumes
of a buffer containing 0.42 M NaCl, 0.1 M
NaI and 0.1 M sodium phosphate buffer, pH
7.5, and 22 µl of 2.5% bovine serum albumin
(BSA) (Sigma), in 0.1 M sodium phosphate
buffer, pH 7.5. Specific activities and
labeling efficiencies were calculated after
trichloroacetic acid precipitation of an aliquot
of the reaction mixture. Free iodine was
separated and both125I-GDNF and 125I-NRTN
were concentrated by using NanoSpin Plus
columns (4000 MWCO, Gelman Sciences,
Ann Arbor, MI, USA). Radioactivity was
measured with a 1271 Riagamma counter
(Wallac, Turku, Finland). 125I-NRTN had a
specific activity of 44.7 µCi/µg, and 125I-
GDNF had a specific activity of 61.3 µCi/µg.
Labeled proteins were bioassayed for
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stimulation of neurite outgrowth from
embryonic day 13.5 mouse trigeminal ganglia
explanted in a collagen matrix and stained
with neurofilament antibodies as described
below.
4.9. Immunohistochemistry (II, III and IV)
Sections were stained by standard
immunohistochemical techniques. Primary
antibodies were detected with an avidin-
biotin-peroxidase system (Vector
Laboratories, Burlingame, CA, USA) with
diaminobenzidine as the chromogen (IV), or
by fluorochrome conjugated secondary
antibodies (II and III). All antibodies were
diluted in PBS with 1% BSA and 0.1% Triton
X-100. Primary antibodies used are given in
Table 4.2.
Table 4.2. Primary antibodies used in immunohistochemistry.
Primary antibody Host/Antibody type Source/Ref. Dilution Used in
PGP9.5 Rabbit polyclonal UltraClone 1:500 II
PGP9.5 Rabbit polyclonal PG9500 Affinity 1:2000 III
Substance P Rat monoclonal NC1 Medicorp 1:300 II
ChAT Goat polyclonal AB144P Chemicon 1:100 II
VIP Rabbit polyclonal VA1285 Affiniti 1:500 II
VAChT Goat polyclonal AB1578 Chemicon 1:1000 II
TH Rabbit polyclonal P40101-0 Pel-Freez 1:500 II, III
S100beta Rabbit polyclonal #36 Swant 1:5000 IV
Vimentin Mouse monoclonal RPN1102 Amersham 1:20 IV
Smooth muscle alfa actin Mouse monoclonal #61001 Progen 1:200 IV
13AA8 Mouse monoclonal Tienari et al. 1987 1:1 III, IV
4.10. Histochemical detection (II and III)
Intestinal samples were opened along
their mesenteric border, washed in PBS,
pinned on silicone without stretching, and
postfixed in 4% PFA for 2 hr. The mucosal
layer was removed, and the muscle layer was
whole-mount stained for AChE or
nicotinamide adenine dinucleotide phosphate
(NADPH)-diaphorase (II). AChE
histochemistry was performed as described
by Tago et al. (1986), except that 1% Triton
X-100 was included in the staining solution
to increase penetration (II). NADPH-
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diaphorase histochemistry was performed as
described by Vincent (1992) (II). Briefly,
whole-mount samples were incubated in 0.1
M sodium phosphate buffer, pH 7.4,
containing 0.3% Triton X-100, 0.1 mg/ml
nitroblue tetrazolium (NBT) and 1.0 mg/ml
NADPH at 37°C for 30-60 minutes.
Following the reaction, the samples were
rinsed in phosphate buffer, pH 7.4, and
mounted.
Sections of the shaft of mice penis were
stained for NADPH-diaphorase
histochemistry as described by Carrier et al.
(1995) (III). Briefly, the shafts of the penises
were fixed for 5 hr in cold 4% PFA in PBS.
Tissues were cryoprotected overnight in cold
30% sucrose in PBS. They were embedded in
Tissue-Tek O.C.T. compound (Sakura,
Zoeterwoude, The Netherlands), frozen on
dry ice and stored at -70°C. Cryostat sections
(10 µm) were prepared and adhered on Super
Frost Plus slides. After a brief air-drying,
sections were hydrated for 10 minutes with
0.1 M sodium phosphate buffer, pH 8.0.
Sections were incubated with 0.1 mM
NADPH, 0.2 mM NBT, 0.2% Triton X-100
in 0.1 M sodium phosphate buffer, pH 8.0,
for 60 minutes at room temperature. The
reaction was stopped by washing the sections
in buffer, and slides were coverslipped with a
Mowiol-based mounting medium.
4.11. Ganglion explant culture (II, III and
IV)
E13-E13.5 mouse trigeminal ganglia
were prepared and cultured in three-
dimensional collagen matrix in a humidified
atmosphere of 5% CO2 in air at +37°C for
48-74 hr, fixed and stained with 13AA8
neurofilament antibodies as earlier described
(Ebendal 1989; Arumäe et al. 1993).
Recombinant GDNF and NRTN were applied
at concentrations ranging from 1 to 100
ng/ml. For controls, trigeminal ganglia were
cultured without GDNF or NRTN.
4.12. Generation and analysis of GFRα2-/-
mice (II and III)
Generation of GFRα2-/- mice is
described in detail in (II).
Immunohistochemical as well as
histochemical stainings were used to compare
the innervations of GFRα2-/- and wild-type
mice. Lacrimal gland secretion was studied
by a modified Schirmer test (Humphreys-
Beher et al. 1994), and the contractile activity
of the gut was mesured in vitro with a Grass
FT03 force displacement transducer coupled
to a Grass model 7D polygraph. Serum
growth hormone (GH) concentrations were
determined by radioimmunoassay using a rat
GH kit (a gift from the National Institute of
Diabetes and Digestive and Kidney
Diseases). Neuronal survival assays for E14
(±1) trigeminal ganglion neurons were
performed as described by Davies (1995).
Briefly, ganglia were digested by trypsin and
cultures were purified by preplating. The
cultures received GDNF, NRTN or NGF at
different concentrations. After 30-35 hr the
neurons were fixed and the healthy neurons
were counted.
32
5. RESULTS
5.1. Kainate-induced expression of GFRα1
and Ret mRNAs in rat brain (I)
In normal rat brain strong GFRα1
mRNA expression was detected in the medial
habenular nucleus, the reticular thalamic
nucleus, and the zona incerta by in situ
hybridization. The message was also
detectable in the hippocampus in CA1-CA3
and the dentate gyrus. Lower levels of
GFRα1 message were detected in the deep
layers of the parietal cortex, the dorsal
endopiriform nucleus, and the amygdala. In
kainate-treated animals 12 hr after injection,
GFRα1 mRNA was dramatically upregulated
in the hippocampus, the medial habenular and
reticular thalamic nuclei, and the zona
incerta, as well as in the deep cortical layers
and the dorsal endopiriform nucleus. In the
hippocampus, a strong increase was seen in
CA3 and the dentate gyrus 6 hr after kainate-
treatment, with a further increase 12 hr after
injection. In contrast, the levels of GFRα1
expression in CA1 and CA2 were maximal at
6 hr and were already decreased at 12 hr.
Ret mRNA was expressed at very low
levels in normal rat brain. A weak signal was
detected in the reticular thalamic nucleus and
the zona incerta. After kainate-treatment the
message was induced in the hilar region of
the hippocampus, in the CA3 region and the
dentate gyrus. In addition, a clear induction
was seen in the medial amygdaloid nucleus
and the piriform cortex.
5.2. Kainate-induced expression of GFRα1
and Ret mRNAs in the rat hippocampus
(I)
Northern analysis showed that both Ret
and GFRα1 mRNA levels were elevated in
the rat hippocampus after kainate treatment
(12 mg/kg, i.p.). The highest levels of both
mRNAs in hippocampus were detected 12 hr
after injection, whereas 24 hr after kainate
treatment the Ret and GFRα1 mRNA levels
returned almost to control levels. A maximal
2.5-fold increase in Ret mRNA and a 4-fold
increase in GFRα1 mRNA were observed.
Injection of the protein synthesis inhibitor
cycloheximide (8 mg/kg, i.p.) 30 min prior to
the kainate injection significantly reduced
GFRα1 mRNA expression (p<0.05), but not
that of Ret (p>0.05), whereas injection of the
N-methyl-D-aspartate (NMDA) receptor
antagonist MK-801 (1 mg/kg, i.p.), 30 min
prior to the kainate injection, did not
significantly affect the induction of Ret or
GFRα1 mRNA levels.
5.3. Analysis of GFRα2-deficient mice (II)
A predicted GFRα2 null allele was
created by deleting part of the first coding
exon using homologous recombination in
embryonic stem cells. The heterozygotes
appeared normal and were fertile, and their
intercrossing resulted in the birth of
homozygotes at the expected frequency
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(57/250), indicating no increased lethality in
the homozygous animals. In situ analysis of
GFRα2 expression in brain sections of adult
wild-type and mutant mice with a GFRα2
exon 1 probe showed a strong signal in wild-
type mice but no signal in mutant mice.
However, similar but much weaker
expression was seen in mutant mice using a
full-length GFRα2 probe, suggesting the
existence of a transcript under the control of
the GFRα2 promoter. Consistent with in situ
hybridization, Northern analysis with the
probe spanning exons 2 and 3 showed that
mutant mice lack all mRNAs, except for an
upregulated transcript of about 0.5 kb. The
hypothetical translation of this transcript
would lead to a short, nonglycosylated,
cytoplasmic peptide suggesting that mutant
mice most likely represent a true null allele.
At birth, the homozygous mutants appeared
normal in size, but at weaning they were
smaller than their wild-type littermates. Many
of the homozygous mutants displayed
apparent ptosis by keeping their eyes partially
closed.
5.3.1. Ptosis-like phenotype and poor growth
of GFRα2-deficient mice
Growth failure of GFRα2-deficient
mice became visible 2-3 weeks after birth and
was most prominent at the age of 4-6 weeks.
At this age the difference between mutant and
wild-type mice was 30-50%. Therefore, the
mutant mice were easily distinguished based
on size. In both sexes the difference in weight
persisted beyond 4 months of age. Consistent
with growth retardation, most organs were
smaller in mutant mice although histological
analysis did not show obvious defects in the
respective organs. Possible malnutrition of
mutant mice is supported by the finding that
their serum albumin was reduced by 15%.
The apparent ptosis was detected in many of
the GFRα2-deficient mice. The ptosis was
variable being unilateral in many animals,
and many mice kept their eyes closed only
part of the time. However, there was no
difference in the sympathetic innervation of
the eyelid muscles.
5.3.2. Defects in cholinergic innervation of
the lacrimal and salivary glands of GFRα2-
deficient mice
GFRα2-deficient mice showed almost a
complete lack of immunostaining of their
nerve fibers in the lacrimal gland with the
PGP9.5 antibody, a panneuronal marker. The
parasympathetic fibers were virtually absent,
as revealed by staining for VAChT, whereas
the sympathetic innervation around the blood
vessels was intact. The acini were enlarged
and the acinar cells appeared atrophied. In
addition, preliminary analysis suggested that
tear secretion was significantly reduced in
mutant mice.
In addition, a dramatic reduction in the
VIP-immunoreactive innervation of the
sublingual and parotid salivary glands was
observed. Consistent with this observation,
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the number of submandibular ganglion
neurons was reduced by about 80%.
5.3.3. Deficient myenteric plexus and
impaired intestinal contractile activity in
GFRα2-deficient mice
In the myenteric plexus of GFRα2-
deficient mice, the density of the fine AChE-
positive fiber network was decreased by 45%,
35%, and 15% in the duodenum, jejunum and
colon, respectively. Correspondingly,
substance P-positive fibers, which are known
to be cholinergic, were clearly reduced in
mutant mice. The density of NOS-containing
nerve cell bodies and fibers in the myenteric
plexus was similar between wild-type and
mutant mice, as revealed by NADPH-
diaphorase histochemistry. However, the
density of neuronal cells in the myenteric
plexus was slightly reduced, as revealed by
cuprolinic blue staining. Analysis of GFRα1
and GFRα2 mRNA expression showed that
GFRα1 mRNA is downregulated in the
postnatal gut, whereas GFRα2 mRNA is
upregulated in the bowel at postnatal day (P)
14. There were clear differences in
spontaneous contractile activity of duodenum
and ileum between wild-type and mutant
mice. The wild-type mice showed more
robust contractions and a more pronounced
pattern of gut movements than the GFRα2-
deficient mice. However, there was no
difference in the frequency of the myogenic
contractions. The contractions of the ileum,
induced either by a supramaximal
concentration of carbachol (3 mM) or
electrical field stimulation, were clearly
reduced in mutant mice. Both the carbachol-
and electrical field stimulation-induced
contractions were inhibited by tetrodotoxin
(0.5 µM).
5.3.4. Reduced NRTN-induced neurito-
genesis and cell survival of GFRα2-
deficient trigeminal neurons
NRTN (5ng/ml) induced a prominent
neurite outgrowth in E13 embryonic
trigeminal ganglion explants of wild-type
mice, whereas only few neurites were seen in
the trigeminal ganglia of GFRα2-deficient
mice. Interestingly, with higher
concentrations (100 ng/ml), NRTN induced
moderate and morphologically different
neurite outgrowth also in mutant ganglia. An
intermediate neurite outgrowth was induced
from ganglionic explants prepared from
GFRα2+/- mice. In explants prepared from
wild-type mice higher concentrations of
NRTN or GDNF evoked the fasciculation of
fibers.
Both NRTN and GDNF kept alive
about 12% of plated E14 trigeminal neurons
at nearly saturating concentrations (100
ng/ml). At lower concentrations GDNF
maintained more neurons than NRTN. In
contrast to wild-type neurons, mutant neurons
were about ten-fold less sensitive to NRTN,
whereas their response to GDNF was
unaltered. Direct counting of neurons from
Nissl-stained paraffin sections of trigeminal
ganglia revealed no significant difference
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between wild-type and GFRα2-deficient
mice.
5.4. Expression of NRTN and GDNF
mRNAs in the pelvic organs of the adult
rat (III, IV)
In situ hybridization revealed a strong
signal for GDNF in the cell layer located in
the narrow area between the tunica albuginea
and the cavernous tissue, whereas a weak and
diffuse signal was seen in the cavernous
tissue. Staining of adjacent sections with
antibodies to vimentin or S100beta revealed
immunoreactivity in many of these subtunical
cells, whereas staining with antibodies to
PGP9.5 or smooth muscle alpha actin
revealed no subtunical immunoreactivity.
NRTN mRNA was widely expressed in the
smooth muscle of penile blood vessels and
the corpus cavernosum. A signal was
observed both in arteries and veins, and to
some extent also in the epithelium of the
urethra.
Northern analysis revealed a single
NRTN transcript of 0.9 kb in all the pelvic
organs studied. The highest expression was
seen in the urinary bladder, penis and vasa
deferentia, whereas the signal was weaker for
the colon, prostate and seminal vesicles. In
contrast to the wide expression of NRTN, a
GDNF transcript of 4.4 kb was detected only
in the shaft of the penis, while there was no
detectable signal in the urinary bladder,
colon, prostate, vasa deferentia or seminal
vesicles.
5.5. Expression of NRTN and GDNF
mRNAs in the penis after cavernous nerve
axotomy (IV)
Expression of GDNF mRNA in the
shaft of adult rat penises was clearly lowered
1, 3 and 7 days after bilateral cavernous nerve
axotomy, and had almost regained the level
of the sham operated rats on day 14. The
level of NRTN mRNA transcripts was the
same in the sham operated and bilateral
neurotomy group on days 3 and 14, and only
slightly, if at all, lowered on days 1 and 7.
5.6. Expression of Ret and GFRα1-3
mRNAs in the MPG and the S1 DRG of
the adult rat (III, IV)
Ret and GFRα2 mRNAs were
expressed in most if not all neurons of the
adult rat MPG, whereas GFRα1 and GFRα3
mRNAs were expressed only in
subpopulations of the MPG neurons. Both
GFRα1 and GFRα3 coreceptors were
expressed in virtually all big-sized, i.e.
sympathetic neurons but only in
subpopulations of the small-sized, i.e.
cholinergic neurons of the MPG.
Accordingly, the expression of Ret and
GFRα2 mRNAs was seen in virtually all
penis-projecting, i.e. fluorogold (FG)-positive
MPG neurons, while the expression of
GFRα1 and GFRα3 mRNAs was seen in
about 54% and 5% of the penis-projecting
neurons, respectively.
Quantitative data of the expression of
Ret, GFRα1, GFRα2 and GFRα3 mRNAs in
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penile MPG and S1 DRG neurons of adult rat
are presented in Table 5.1. There was a
differential distribution of receptor mRNAs
within the S1 DRG cells according to cell
size. Ret, GFRα2 and GFRα3 mRNAs were
expressed preferentially in small and
intermediate-sized cells, whereas GFRα1
mRNA was expressed preferentially in
intermediate- and large-sized cells. There was
no detectable expression of NRTN or GDNF
mRNAs in the MPG or the S1 DRG of adult
rat.
Table 5.1. Quantative data of the expression of
Ret and GFRα1-3 mRNAs in penile MPG and
S1 DRG neurons.
MPG (%) S1 DRG (%)
Ret 100.0      (384) 62.0±3.5 (398)
GFRα1 53.9±2.5 (396) 57.1±4.0 (443)
GFRα2 98.4±1.5 (426) 6.3±2.4   (459)
GFRα3 5.3±2.6   (414) 45.6±6.3 (505)
The expression of receptor mRNAs in FG-labeled
neurons was quantified unilaterally in three rats.
Values represent mean±S.D.; total number of
neurons analyzed in parentheses.
5.7.
 
Retrograde axonal transport of 125I-
NRTN and 125I-GDNF in penis-projecting
neurons (III, IV)
Both 125I-NRTN and 125I-GDNF
induced strong neurite outgrowth in mouse
embryonic E13 trigeminal ganglia, while
there were no neurites in control ganglia
cultured in the absence of neurotrophic
factors. 125I-labeled and nonlabeled proteins
exhibited similar neuritogenic efficacy at all
concentrations tested (1-20 ng/ml). 24 hrs
after injection of 200 ng of 125I-NRTN or 125I-
GDNF into both corpora cavernosa,
autoradiography revealed clustered silver
grains in the MPG and the S1 DRG. The
retrograde transport was blocked when 125I-
proteins were injected together with excess
unlabeled proteins, whereas excess
cytochrome c did not block the transport.
5.8.
 
Loss of NADPH diaphorase staining in
the penile nerves of GFRα2-/- mice (III)
On histochemical examination of the
proximal part of the shaft and the crura penis
from wild-type and GFRα2-/- mice, a
significantly different pattern of NADPH
diaphorase-positive nerve fibers was noted.
GFRα2-/- mice had very few NADPH
diaphorase-positive fibers in the dorsal penile
nerves, while the fiber density in wild-type
mice was similar to that reported in rats
(Carrier et al. 1995). There was no clear
difference in the staining pattern of nerves
supplying cavernosal vessels in the crura.
However, in the crura the number of NADPH
diaphorase-positive fibers was significantly
reduced outside the perivascular area. In
contrast, no difference was noted in the
density of the tyrosine hydroxylase-positive
fibers in the crura penis.
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6. DISCUSSION
6.1. Regulation of GFRα1 and Ret mRNAs
in rat brain by kainate-induced seizures (I)
Kainate-induced seizures, a widely
studied model of neuronal plasticity and
human epilepsy (Ben-Ari 1985), have been
shown to increase in rat hippocampus gene
expression of several trophic factors,
including GDNF (Humpel et al. 1994). The
results of the present study show that GFRα1
and Ret mRNAs are differentially expressed
and upregulated in adult rat brain following
kainate-induced seizures. In agreement with
the results of other studies (Trupp et al. 1997;
Widenfalk et al. 1997; Kokaia et al. 1999),
GFRα1 mRNA expression was widespread
as compared to Ret mRNA, which was
expressed at very low levels. Ret and GFRα1
mRNAs were upregulated in several brain
structures, with maximum levels in the
hippocampus 12 hr after kainate
administration. Ret mRNA upregulation was
detectable in the hippocampal formation,
reticular thalamic nuclei, zona incerta,
amygdala and piriform cortex, whereas
GFRα1 mRNA was upregulated in the
habenular and reticular thalamic nuclei,
hippocampus, deeper layers of the parietal
cortex and the dorsal endopiriform nucleus.
Recently Trupp et al. (1998) reported that in
rat brain also the GFRα2 mRNA levels could
be induced by kainic acid treatment
(0.35µg/0.5µl, i.c.v., bilaterally). A
pronounced elevation was seen in thalamus
and the dentate gyrus 12 hr after stimulation
with kainic acid (Trupp et al. 1998). GDNF
mRNA expression is increased in scattered
neurons in the dentate granule layer 3 hr after
injection of kainate (12 mg/kg i.p.), and after
6 hr almost all dentate granule cells expressed
GDNF mRNA (Humpel et al. 1994). Trupp et
al. (1997) reported that 12 hr after kainic acid
treatment (0.35µg/0.5µl, i.c.v., bilaterally),
increased GDNF mRNA levels were
observed in all regions of the hippocampus.
Thus, there are similarities and differences in
the spatial and temporal expression patterns
of GDNF, Ret and GFRα1 mRNAs in rat
brain before and after kainate-induced
epileptic seizures. The expression patterns of
GFRα1 and Ret are in agreement with the
neuroprotective properties of GDNF. Martin
et al. (1995) showed that GDNF prevents
kainate-induced seizures and seizure-
associated neuronal cell loss in the
hippocampus, thalamus and amygdala.
GDNF provides also potent protection against
brain infarction (Wang et al. 1997) and
transient forebrain ischemia (Miyazaki et al.
1999).
While the present study (I) was being
reviewed, Trupp et al. (1997) using in situ
hybridization reported in detail GDNF
receptor mRNA expression in normal rat
brain, as well as following kainate-induced
seizures. Although they applied i.c.v.
injection of kainate their data essentially
agree with our results. These results are also
well in line with upregulation of Ret and
GFRα1 mRNAs in rat hippocampus after
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kindling-evoked seizures (Kokaia et al.
1999).
There are at least two possible
mechanisms for the regulation of Ret and
GFRα1 gene expression after kainate-
induced seizures. First, their transcription
could be activated directly by depolarizing
neuronal activity, glutamate release and
calcium influx. These mechanisms have been
suggested to explain the upregulation of
GDNF mRNA after seizures (Humpel et al.
1994; Ho et al. 1995), as well as of
neurotrophins (NGF and BDNF) (Zafra et al.
1990; Gall et al. 1991), and numerous other
genes induced in the hippocampus by kainate
(Nedivi et al. 1993; Kasof et al. 1995).
Second, it is possible that upregulation of
these receptors may be mediated by GDNF.
This idea is consistent with the fact that
GDNF upregulation occurs earlier than that
of Ret and GFRα1. For several reasons the
data presented suggest that upregulation of
GDNF-receptors is primarily due to the
neuronal activity per se and not to the
neuronal cell death occurring after kainate-
induced seizures. First, MK-801 blocks
kainate-induced behavioral seizures and cell
death (Humpel et al. 1994), but does not
block kainate-induced upregulation of Ret
and GFRα1 mRNAs. Second, although
pentylenetetrazole-induced seizures do not
produce neuronal cell death (Schreiber et al.
1993) they elevated the levels of GDNF
receptor mRNAs.
A co-expression of trophic factors and
their receptors within the hippocampal
formation is well documented for
neurotrophins. Many hippocampal cells
express trkB and trkC mRNAs (Merlio et al.
1993), as well as their ligands, BDNF and
neurotrophin (NT)-3 (Ernfors et al. 1990),
while trkA, the cognate receptor of NGF, is
not expressed at all in the hippocampus. In
comparison with the BDNF and NGF, the
time-course of the induction of GDNF and its
receptors seems to be slower (Zafra et al.
1990; Trupp et al. 1997). The present study
shows that, following an epileptic insult, Ret
and GFRα1 mRNAs are upregulated in
several brain regions. However, the level and
localization of mRNA do not necessarily
reflect the level and localization of proteins.
For example, BDNF mRNA is upregulated in
rat hippocampus more than 20-fold by
kainate-induced seizures, whereas the BDNF
protein is elevated only two- to three-fold
(Lindvall et al. 1994). Recently, Mikuni et al.
(1999) reported that the GDNF protein level
was upregulated in dentate granule cells 3 hr
after kainate-induces seizures, continued to
increase until post-injection day 4, and
returned to the control level by day 7. It has
not been reported whether also the protein
levels of Ret and GFRα1 are elevated after
kainate-induced seizures.
Consistent with the results of several
groups (Trupp et al. 1997; Golden et al. 1998;
Yu et al. 1998), GFRα1 mRNA was seen
without Ret mRNA in several brain regions,
most notably in the cortex. In these brain
regions GFRα1 could capture and present
GDNF or NRTN to afferent axons expressing
Ret (Trupp et al. 1997; Yu et al. 1998). This
interaction ”in trans” has been suggested to
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occur, e.g. between thalamic afferent neurons
that transcribe high levels of Ret, and cortical
neurons, that show high expression of
GFRα2 mRNA (Yu et al. 1998).
Alternatively, GFRα1 could signal by itself,
as has been previously reported (Poteryaev et
al. 1999; Trupp et al. 1999). It is also possible
that other signaling components may exist in
addition to Ret. This idea is supported by the
observation that GDNF promotes the survival
of postnatal rat cochlear neurons, which
express GFRα1 mRNA but lack detectable
levels of Ret mRNA (Ylikoski et al. 1998).
In conclusion, the present results
suggest that increased levels of the GDNF
receptors, Ret and GFRα1, may further
amplify the putative responses to GDNF
following epileptic seizures. This insult–
induced cascade may provide and facilitate a
local trophic support within the hippocampus
that both protects against neuronal death
following an epileptic insult and maintains or
reorganizes the neuronal connections in the
normal adult hippocampus.
6.2. Physiological role of the coreceptor
GFRα2 (II)
6.2.1. Physiological pairing of GFRα2 and
neurturin
Results from in vitro assays suggest
that GFRα2 mediates activation of Ret by
both NRTN and GDNF (Baloh et al. 1997;
Buj-Bello et al. 1997; Creedon et al. 1997;
Klein et al. 1997). However, the ligand
specificities of the GFRα receptors appear
complex, differing in the presence and
absence of Ret. Transcripts of Ret and the
GFRα receptors are expressed in temporally
and spatially distinct, but partially
overlapping patterns in the developing
embryo and adult mice (Golden et al. 1998;
Naveilhan et al. 1998; Golden et al. 1999).
NRTN and GFRα2 show complementary
expression patterns in several organs, e.g.
developing teeth and salivary gland,
suggesting that NRTN and GFRα2 may be
physiologically coupled in vivo (Luukko et al.
1997; Widenfalk et al. 1997; Golden et al.
1999). To assess the in vivo function of the
coreceptor GFRα2 and the physiological
ligand specificity, GFRα2-/- mice were
generated. The striking similarity of the
phenotypes of mice lacking GFRα2 or
NRTN, which includes deficits in
parasympathetic and enteric neurons, support
the idea that GFRα2 serves as a primary
physiological coreceptor for NRTN
(Heuckeroth et al. 1999). Both GFRα2-/- and
NRTN-/- mice suffer a nearly complete lack
of parasympathetic innervation of the
lacrimal and salivary glands, show
comparable reduction in the nerve fiber
density of the myenteric plexus and
disordered gastrointestinal motility. No
striking abnormalities were observed in the
central nervous system of GFRα2-/- mice
despite the fact that adult mouse brain
express high levels of GFRα2 (Golden et al.
1998). The lack of severe defects in the
central nervous system may reflect the
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tendency of its neurons to rely on multiple
trophic factors simultaneously (Snider 1994).
There was no significant difference in
the number of trigeminal ganglion neurons
between wild-type and GFRα2-/- mice.
Moreover, in GFRα2-/- mice the nodose
ganglia and the DRGs appeared to be of
equivalent size as compared to those in wild-
type mice. In contrast, NRTN-/- mice have
been shown to display a 70% reduction in the
number of GFRα2-expressing trigeminal
ganglion neurons, and a 45% reduction in
GFRα2-expressing DRG neurons
(Heuckeroth et al. 1999). These defects,
which are small in the absolute number of
neurons, were not detected in GFRα2-
deficient mice, probably due to differences in
detection methods. Despite the striking
similarity between the GFRα2-/- and NRTN-/-
mice, they display one clear difference.
GFRα2-/- mice grow poorly after weaning,
whereas NRTN-/- mice grow normally
(Heuckeroth et al. 1999). The etiology of the
growth difference remains unclear. One
possibility is that GDNF could substitute
NRTN and activate GFRα2 in areas
important for growth (Heuckeroth et al.
1999). Another possibility is that the
difference in growth reflects differences in
strain genetic background or diet.
The idea of physiological pairing of
NRTN and GFRα2 is further enforced by the
observation that NRTN induced a prominent
neurite outgrowth in E13 embryonic
trigeminal ganglion explants of wild-type
mice, whereas only a few neurites were seen
in the trigeminal ganglia of GFRα2-deficient
mice. Moreover, GDNF induced neurite
outgrowth in trigeminal ganglia explants of
GFRα2-deficient and wild-type mice
appeared indistinguishable. Interestingly,
with higher concentrations, NRTN induced
moderate neurite outgrowth also from mutant
ganglia. In dissociated neuronal culture
GFRα2-/- sensory neurons no longer
responded to physiological concentrations of
NRTN. These data are consistent with
previous in vitro results which show that
GFRα2 is the primary coreceptor for NRTN,
but not for GDNF, and that NRTN may at
high concentrations signal via GFRα1 (Baloh
et al. 1997; Buj-Bello et al. 1997; Jing et al.
1997; Klein et al. 1997). The phenotypes of
GDNF-family ligand- and receptor-deficient
mice are summarized in Appendix I.
6.2.2. Role of GFRα2 in development/
maintenance of enteric neurons
GFRα2-deficient mice have a reduction
in the density of the nerve fibers of the
myenteric plexus and disordered
gastrointestinal motility, whereas the
reduction in number of enteric neurons is
minimal. These defects are strikingly similar
to those observed in NRTN-/- mice
(Heuckeroth et al. 1999). In culture both
GDNF and NRTN similarly increase
proliferation and process formation of
developing enteric neurons (Chalazonitis et
al. 1998; Hearn et al. 1998; Heuckeroth et al.
1998). Although the effects of these factors
are indistinguishable in culture, their
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physiological role in vivo seems to be very
different. GDNF- as well as GFRα1-deficient
mice fail to develop their enteric nervous
system, most probably as a result of
insufficient proliferation of enteric precursor
cells and increased cell death (Moore et al.
1996; Pichel et al. 1996; Sanchez et al. 1996;
Cacalano et al. 1998; Enomoto et al. 1998),
whereas the defects in the enteric nervous
system in NRTN- and GFRα2-deficient mice
are much smaller without significant
reduction in the number of enteric neurons.
These results suggest that GDNF and GFRα1
are required for early development of the
enteric nervous system, whereas NRTN and
GFRα2 are crucial for postmitotic myenteric
neurons. This idea is further supported by the
observation that GFRα1 mRNA is
downregulated in the postnatal gut of wild-
type mice, whereas GFRα2 mRNA is
upregulated in the bowel at postnatal day 14.
Interestingly, GFRα2 mRNA expression is
variable along the gastrointestinal tract being
most prominent in the small bowel. The
expression of GFRα2 mRNA is increased at
the time when the development of the
cholinergic myenteric plexus is accomplished
(Vannucchi and Faussone-Pellegrini 1996).
Moreover, expression of GDNF in the
postnatal gut is very low, whereas NRTN
expression is increased to a high level in the
adult gut (Golden et al. 1999).
6.2.3. Role of GFRα2 in development/
maintenance of parasympathetic neurons
The parasympathetic innervation was
almost absent in the lacrimal and salivary
glands of GFRα2-deficient mice. This is
consistent with the expression of GFRα2 and
Ret mRNAs in parasympathetic ganglia
within the submandibular gland as well as in
the pterygopalatine ganglion, and with the
high level of NRTN mRNA expression in the
submandibular and lacrimal glands of
developing mouse (Golden et al. 1999).
Interestingly, not all parasympathetic neurons
were lost, as the ciliary ganglion and the
pupillary reflex of GFRα2-deficient mice
appeared normal. However, adult NRTN-
deficient mice have almost a 50% reduction
in the number of ciliary ganglion neurons
(Heuckeroth et al. 1999). The size of
individual otic ganglion cells, but not the
number of neurons, was reduced in neonatal
NRTN-deficient mice as compared to wild-
type animals (Heuckeroth et al. 1999).
Whether GFRα2-deficient mice have a
similar defect in the ciliary and otic ganglia
remains to be studied. The observation that
GFRα2-mediated signaling is important for
the development or maintenance of the
parasympathetic neurons is consistent with
the defect in parasympathetic neurons in mice
lacking Phox2a or Phox2b, which are
transcription factors that regulate the
expression of Ret (Morin et al. 1997; Lo et al.
1998; Pattyn et al. 1999). Although GFRα2 is
widely expressed in the developing as well as
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in the mature peripheral nervous system
(Baloh et al. 1997; Naveilhan et al. 1998;
Golden et al. 1999; Nishino et al. 1999),
GFRα2-/- mice show most prominent defects
in their parasympathetic ganglia. The lack of
major abnormalities in sympathetic ganglia,
e.g. the superior cervical ganglion or sensory
ganglia, is likely attributable to a functional
redundancy among GFRα proteins.
6.3. GDNF family ligands and their
receptors in the innervation of the penis
(III, IV)
6.3.1. Expression of GDNF and NRTN
mRNAs in the penis and other pelvic organs
The discovery of GDNF and NRTN
was soon followed by the demonstration of
their ability to promote survival of several
neuronal populations in the peripheral and
central nervous system (Airaksinen et al.
1999; Saarma and Sariola 1999). However,
the possible significance of GDNF family
ligands as neurotrophic factors for pelvic
neurons has not been previously studied. In
this study it is shown that both NRTN and
GDNF mRNAs are expressed in the shaft of
adult rat penis. In situ hybridization revealed
differences between the expression patterns
of NRTN and GDNF in the adult rat penis.
NRTN mRNA was expressed in penile
smooth muscle in close coincidence with the
neuron-target contact, whereas GDNF
expression was focused to the subtunical cell
layer in the shaft of the penis. Our results
suggest that the GDNF mRNA expressing
cells are likely to be of mesenchymal origin,
since many subtunical cells displayed
immunoreactivity for vimentin, which is
considered as a marker of mesenchymal cells
(Leader et al. 1987). In contrast to the
expression of GDNF, NRTN expression was
also seen in several intrapelvic organs. These
results suggest that endogenously produced
NRTN may work as a target-derived
neurotrophic factor in several pelvic organs,
whereas the role of GDNF may be more
restricted. However, the possibility that
GDNF mRNA is expressed in some pelvic
organs in amounts below the level of
detection can not be exclude. This could be
expected since GDNF receptor components
are widely expressed in the MPG neurons of
adult rat.
In order to find out whether GDNF and
NRTN mRNA synthesis in the penis is under
neuronal control, expression of their mRNAs
was studied after bilateral cavernous nerve
axotomy. The observation that NRTN mRNA
expression in the shaft of the penis was not
remarkably altered after bilateral cavernous
nerve axotomy is consistent with the results
of several denervation experiments of
autonomic nerves in neonatal and adult
animals. For example, NGF mRNA levels
remain unchanged after sympathectomy in
the neonatal rat heart as well as in the iris of
adult rat (Shelton and Reichardt 1986; Clegg
et al. 1989). Surprisingly, GDNF mRNA
expression was transiently downregulated in
the penis following bilateral cavernous nerve
axotomy. The cellular and molecular
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mechanism of this phenomenon is, however,
still unknown, and its physiological
significance remains to be established.
6.3.2. Expression of Ret and GFRα1-3
mRNAs in the MPG and the S1 DRG of the
adult rat
The results also demonstrate that
practically all the penis-innervating as well as
most other MPG neurons express mRNAs for
the NRTN receptor components GFRα2 and
Ret. In addition, the coreceptors GFRα1 and
GFRα3 were detected in subpopulations of
penile MPG neurons as well as in most other
MPG neurons. These data conform to the
idea that in adult rat certain GDNF-family
members may be maintenance factors not
only for pelvic parasympathetic, but also for
pelvic sympathetic neurons. The wide
coexpression of GFRα1, GFRα2 and GFRα3
 
mRNAs in MPG neurons, escpecially in
sympathetic MPG neurons, suggests that
several GDNF family ligands may exert
trophic effects on the same neurons in adult
rat MPG. Similar partially overlapping
expression of GFRαs has been demonstrated
in the central nervous system as well as in
other parts of the peripheral nervous system
(Golden et al. 1998; Naveilhan et al. 1998;
Golden et al. 1999). Interestingly, a
subpopulation of small-sized neurons in the
MPG express mRNA only for the coreceptor
GFRα2, but not for GFRα1 or GFRα3.
Whether there is a functional distinction
between neurons expressing mRNAs for
different combinations of GFRαs remains to
be studied.
6.3.3. Retrograde axonal transport of 125I-
GDNF and 125I-NRTN in penis projecting
MPG and DRG neurons
In addition to expression in the target
cells, neurotrophic factors need to be
internalized and retrogradely transported in
order to be able to exert their biological
effects in neuronal somata (Korsching 1993).
Indeed, retrograde axonal transport from
nerve terminals to neuronal somata is an
important criterion for the physiological
significance of a neurotrophic factor
candidate. Recently Leitner et al. (1999)
reported selective receptor-mediated transport
of NRTN and GDNF in sensory and
motoneurons of adult rat. After intrastriatal
injection GDNF is retrogradely transported
also by mesencephalic dopamine neurons
(Tomac et al. 1995). The present study
demonstrates the binding, uptake and
retrograde axonal transport of 125I-NRTN and
125I-GDNF in penis-projecting MPG and
DRG neurons of adult rat. This supports the
hypothesis that endogenously produced
NRTN and GDNF may have physiological
roles as trophic factors for these neurons. The
fact that 125I-labelled GDNF family ligands,
with a neurite outgrowth promoting activity
comparable to that of the unlabeled parent
proteins, were transported in the presence of
a 100-fold excess of cytochrome c but not in
the presence of a similar excess of parent
proteins, suggests that the retrograde
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transport was mediated by binding to specific
receptors on the axon terminals. This is
further supported by the observation that, 24
hr after injection of 125I-labelled proteins into
the shaft of the penis, significant amounts of
radioactivity were detected only in the MPG
and the S1 DRG, which are the principal
ganglia known to innervate the rat penis (Dail
et al. 1989).
6.3.4. Role of the GFRα2 coreceptor in the
development and/or maintenance of penile
nitrergic innervation
The observation that there are defects
in some but not all parasympathetic neurons
in GFRα2-/- mice led us to study whether the
penile nitrergic innervation is affected by
ablation of the GFRα2 gene. It was found
that GFRα2-deficient mice had a
significantly reduced number of nNOS-
containing fibers in the dorsal nerves and the
crura penis, whereas the penile sympathetic
noradrenergic (TH-immunopositive)
innervation, which derives from the
paravertebral chains (de Groat and Booth
1993), appeared to be normal. Further studies
are needed to show whether the decreased
nitrergic fiber density in the penis is due to
loss of neurons or reduced axonal
arborization. Whatever the reason(s), these
results provide evidence for a functional role
of GFRα2-mediated signaling in penile MPG
neurons. This view may for several reasons
be correct despite the observation that
GFRα2-/- mice are capable of reproduction.
First, the present results do not exclude subtle
deficits in reproductive performance. Second,
it is common that in mice with gene ablation
compensatory mechanisms take over the
function thought to highly depend on the
deleted gene. For example, mice with
targeted deletion of the neuronal NOS gene
exhibit an increased expression of penile
endothelial NOS (Burnett et al. 1996). The
compensatory action of other GDNF family
members is a possible explanation of the
partial presence of penile NOS-containing
nerves in GFRα2-/- mice. Our results suggest
a compensatory role especially for GDNF,
since its preferred coreceptor GFRα1 is
expressed in more than half of the penile
MPG neurons of adult rat. Although the
similarity of penile neurons between rat and
mice cannot be assumed, the present results
support the idea that GFRα2-mediated
signaling is important for both species. Third,
trophic support by other neurotrophic factors
is also a reasonable possibility (Burgers et al.
1991; Te et al. 1994; Jung et al. 1999).
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7. CONCLUSIONS
1) The present results show that Ret and GFRα1 mRNAs are induced in the rat brain in
response to systemic administration of kainate. The kainate induced upregulation of GFRα1
mRNA, but not Ret mRNA, was significantly suppressed in hippocampus by the protein
synthesis inhibitor cycloheximide. These results suggest that GFRα1 belongs to late responsive
genes, as protein synthesis is necessary for its mRNA’s induction by kainate. MK-801, a NMDA-
receptor antagonist, suppressed the behavioral seizures, but did not significantly suppress
elevated levels of Ret or GFRα1 mRNA, suggesting that non-NMDA receptors are responsible
for the induction of their mRNAs following kainate-induced seizures.
2) GFRα2-/- mice suffered a nearly complete lack of parasympathetic innervation of the
lacrimal and salivary glands, and a 81% reduction in the number of submandibular ganglion
neurons. In addition, these mice show clear reduction in the density of the AChE-positive fiber
network in the myenteric plexus of their small intestine. The striking similarity of the phenotypes
of mice lacking GFRα2 or NRTN, which includes deficits in parasympathetic and enteric
neurons, support the idea that these molecules are components of the same ligand-receptor
complex, and that GFRα2 serves as the primary coreceptor for NRTN.
3) Both NRTN and GDNF mRNAs are expressed in the shafts of adult rat penises. NRTN
mRNA is expressed in penile smooth muscle in close coincidence with the neuron-target
contacts, whereas the expression of GDNF mRNA is focused to the subtunical cell layer in the
shaft of the penis. In contrast to the expression of GDNF mRNA, NRTN mRNA expression is
also seen in several intrapelvic organs. In addition, the penis-innervating as well as most other
MPG neurons, express mRNAs for the GDNF family receptor components Ret and GFRα1-3.
This supports the idea that in the adult rat certain GDNF family members may be maintenance
factors, not only for pelvic parasympathetic, but also for pelvic sympathetic MPG neurons.
4) In the adult rat, penile MPG neurons as well as penile sensory neurons are able to bind,
internalize and retrogradely transport to neuronal somata 125I-GDNF and 125I-NRTN injected into
the shaft of the penis. The fact that the 125I-labelled GDNF family ligands, with a neurite
outgrowth promoting activity comparable to that of the unlabeled parent proteins, were
transported in the presence of a 100-fold excess of cytochrome c but not in the presence of a
similar excess of parent proteins, suggests that the retrograde transport was mediated by binding
to specific receptors on the axon terminals.
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5) On histochemical examination of the proximal part of the shaft and the crura penis from
wild-type and GFRα2-/- mice, a significantly different pattern of NADPH diaphorase-positive
nerve fibers was noted. GFRα2-/- mice had a significant reduction in the number of NADPH
diaphorase-positive fibers in the dorsal penile nerves. In addition, in the crura penis the number
of nNOS-containing fibers was significantly reduced outside the perivascular area. This points to
a physiological role for GFRα2-mediated signaling in penile erection-inducing neurons.
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